<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html id="nojs" xmlns="http://www.w3.org/1999/xhtml" xmlns:m="http://www.w3.org/1998/Math/MathML" xmlns:og="http://ogp.me/ns#" xml:lang="en-GB" lang="en-GB" xmlns:wb=“http://open.weibo.com/wb”>

<head>

   
  
      
  
                  
  
                  
  
            
  
            
            
    <title>Trials | Full text | Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial)</title>
<link rel="shortcut icon" type="image/x-icon" href="/images/icon/10096/favicon.ico" />
<link rel="apple-touch-icon" sizes="72x72" href="/sites/10096/images/70.gif" />
<meta http-equiv="X-UA-Compatible" content="IE=7" />


                
    
		
		
		
		
<!-- <?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:cc="http://web.resource.org/cc/" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">
<cc:Work rdf:about="http://www.trialsjournal.com/content/16/1/37">
<cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
</cc:Work>
<cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
<cc:permits rdf:resource="http://web.resource.org/cc/Reproduction"/>
<cc:permits rdf:resource="http://web.resource.org/cc/Distribution"/>
<cc:requires rdf:resource="http://web.resource.org/cc/Notice"/>
<cc:requires rdf:resource="http://web.resource.org/cc/Attribution"/>
<cc:permits rdf:resource="http://web.resource.org/cc/DerivativeWorks"/>
</cc:License>
<item rdf:about="http://www.trialsjournal.com/content/16/1/37">
<title>Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial)</title>
<dc:title>Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial)</dc:title>
<dc:creator>Berm, Elizabeth JJ</dc:creator>
<dc:creator>Hak, Eelko</dc:creator>
<dc:creator>Postma, Maarten</dc:creator>
<dc:creator>Boshuisen, Marjolein</dc:creator>
<dc:creator>Breuning, Laura</dc:creator>
<dc:creator>Brouwers, Jacobus RBJ</dc:creator>
<dc:creator>Dhondt, Ton</dc:creator>
<dc:creator>Jansen, Paul AF</dc:creator>
<dc:creator>Kok, Rob M</dc:creator>
<dc:creator>Maring, Jan G</dc:creator>
<dc:creator>van Marum, Rob</dc:creator>
<dc:creator>Mulder, Hans</dc:creator>
<dc:creator>Voshaar, Richard C Oude</dc:creator>
<dc:creator>Risselada, Arne J</dc:creator>
<dc:creator>Venema, Harry</dc:creator>
<dc:creator>Vleugel, Liesbeth</dc:creator>
<dc:creator>Wilffert, Bob</dc:creator>
<dc:identifier>info:doi/10.1186/s13063-015-0561-0</dc:identifier>
<dc:identifier>info:pmid/25636328</dc:identifier>
<dc:source>Trials 2015, 16:37</dc:source>
<dc:date>2015-01-31</dc:date>

<prism:publicationName>Trials</prism:publicationName>
<prism:publicationDate>2015-01-31</prism:publicationDate>
<prism:volume>16</prism:volume>
<prism:number>1</prism:number>
<prism:section>Study protocol</prism:section>
<prism:startingPage>37</prism:startingPage>
<prism:copyright>2015 Berm et al.; licensee BioMed Central.</prism:copyright>
</item>
</rdf:RDF>
 -->
 
 
<meta name="citation_journal_title" content="Trials" />
<meta name="citation_publisher" content="BioMed Central Ltd" />


<meta name="citation_author" content="Elizabeth JJ Berm" />
<meta name="citation_author_institution" content="Groningen Institute of Pharmacy, University of Groningen, Unit of Pharmacotherapy & Pharmaceutical Care, Antonius Deusinglaan 1, Groningen, 9713AV, The Netherlands" />
<meta name="citation_author" content="Eelko Hak" />
<meta name="citation_author_institution" content="Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands" />
<meta name="citation_author_institution" content="Groningen Institute of Pharmacy, University of Groningen, Unit of Pharmacoepidemiology & Pharmacoeconomics, Groningen, The Netherlands" />
<meta name="citation_author" content="Maarten Postma" />
<meta name="citation_author_institution" content="Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands" />
<meta name="citation_author_institution" content="Groningen Institute of Pharmacy, University of Groningen, Unit of Pharmacoepidemiology & Pharmacoeconomics, Groningen, The Netherlands" />
<meta name="citation_author" content="Marjolein Boshuisen" />
<meta name="citation_author_institution" content="Lentis, Dignis, Groningen, The Netherlands" />
<meta name="citation_author" content="Laura Breuning" />
<meta name="citation_author_institution" content="Departement of Old Age and Clinical Psychiatry, Reinier van Arkel Group, ‘s-Hertogenbosch, The Netherlands" />
<meta name="citation_author" content="Jacobus RBJ Brouwers" />
<meta name="citation_author_institution" content="Groningen Institute of Pharmacy, University of Groningen, Unit of Pharmacotherapy & Pharmaceutical Care, Antonius Deusinglaan 1, Groningen, 9713AV, The Netherlands" />
<meta name="citation_author_institution" content="Department of Geriatric Medicine and Expertise Centere Pharmacotherapy in Old Persons, UMC Utrecht, Utrecht, The Netherlands" />
<meta name="citation_author" content="Ton Dhondt" />
<meta name="citation_author_institution" content="Department of Old-age Psychiatry, GGZ-Noord Holland Noord, Heerhugowaard, The Netherlands" />
<meta name="citation_author" content="Paul AF Jansen" />
<meta name="citation_author_institution" content="Department of Geriatric Medicine and Expertise Centere Pharmacotherapy in Old Persons, UMC Utrecht, Utrecht, The Netherlands" />
<meta name="citation_author" content="Rob M Kok" />
<meta name="citation_author_institution" content="Department of Old Age, Parnassia Psychiatric Institute, The Hague, The Netherlands" />
<meta name="citation_author" content="Jan G Maring" />
<meta name="citation_author_institution" content="Laboratory for Drug Analysis & Toxicology, Diaconessen Hospital Meppel & Bethesda Hospital Hoogeveen, Meppel, The Netherlands" />
<meta name="citation_author" content="Rob van Marum" />
<meta name="citation_author_institution" content="Department of Geriatric Medicine, Jeroen Bosch Hospital, ‘s Hertogenbosch, The Netherlands" />
<meta name="citation_author_institution" content="Department of General Practice & Elderly Care Medicine, VU University, Amsterdam, The Netherlands" />
<meta name="citation_author" content="Hans Mulder" />
<meta name="citation_author_institution" content="Clinical Pharmacy, Wilhelmina Hospital Assen, Assen, The Netherlands" />
<meta name="citation_author" content="Richard C Oude Voshaar" />
<meta name="citation_author_institution" content="University of Groningen, University Medical Center Groningen, University Center for Psychiatry, Groningen, The Netherlands" />
<meta name="citation_author" content="Arne J Risselada" />
<meta name="citation_author_institution" content="Clinical Pharmacy, Wilhelmina Hospital Assen, Assen, The Netherlands" />
<meta name="citation_author" content="Harry Venema" />
<meta name="citation_author_institution" content="Department of Old Age Psychiatry, GGZ Friesland, Leeuwarden, The Netherlands" />
<meta name="citation_author" content="Liesbeth Vleugel" />
<meta name="citation_author_institution" content="Department of Old Age Psychiatry, GGZ inGeest, Haarlem, The Netherlands" />
<meta name="citation_author" content="Bob Wilffert" />
<meta name="citation_author_institution" content="Groningen Institute of Pharmacy, University of Groningen, Unit of Pharmacotherapy & Pharmaceutical Care, Antonius Deusinglaan 1, Groningen, 9713AV, The Netherlands" />
<meta name="citation_author_institution" content="Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands" />


<meta name="citation_issn" content="1745-6215" />
<meta name="citation_title" content="Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial)" />
<meta name="citation_volume" content="16" />
<meta name="citation_issue" content="1" />
<meta name="citation_date" content="2015-01-31" />
<meta name="citation_firstpage" content="37" />
<meta name="citation_doi" content="10.1186/s13063-015-0561-0" />
<meta name="citation_pdf_url" content="http://www.trialsjournal.com/content/pdf/s13063-015-0561-0.pdf" />
<meta name="citation_pmid" content="25636328" />
<link rel="alternate" type="application/pdf" title="PDF" href="http://www.trialsjournal.com/content/pdf/s13063-015-0561-0.pdf" />
<meta name="title" content="Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial)" />
<meta name="description" content="Nortriptyline and venlafaxine are commonly used antidepressants for treatment of depression in older patients. Both drugs are metabolized by the polymorphic cytochrome P450-2D6 (CYP2D6) enzyme and guidelines for dose adaptations based on the CYP2D6 genotype have been developed. The CYP2D6 Screening Among Elderly (CYSCE) trial is designed to address the potential health and economic value of genotyping for CYP2D6 in optimizing dose-finding of nortriptyline and venlafaxine." />

<meta name="dc.title" content="Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial)" />
<meta name="dc.creator" content="Berm, Elizabeth JJ" />
<meta name="dc.creator" content="Hak, Eelko" />
<meta name="dc.creator" content="Postma, Maarten" />
<meta name="dc.creator" content="Boshuisen, Marjolein" />
<meta name="dc.creator" content="Breuning, Laura" />
<meta name="dc.creator" content="Brouwers, Jacobus RBJ" />
<meta name="dc.creator" content="Dhondt, Ton" />
<meta name="dc.creator" content="Jansen, Paul AF" />
<meta name="dc.creator" content="Kok, Rob M" />
<meta name="dc.creator" content="Maring, Jan G" />
<meta name="dc.creator" content="van Marum, Rob" />
<meta name="dc.creator" content="Mulder, Hans" />
<meta name="dc.creator" content="Voshaar, Richard C Oude" />
<meta name="dc.creator" content="Risselada, Arne J" />
<meta name="dc.creator" content="Venema, Harry" />
<meta name="dc.creator" content="Vleugel, Liesbeth" />
<meta name="dc.creator" content="Wilffert, Bob" />
<meta name="dc.description" content="Nortriptyline and venlafaxine are commonly used antidepressants for treatment of depression in older patients. Both drugs are metabolized by the polymorphic cytochrome P450-2D6 (CYP2D6) enzyme and guidelines for dose adaptations based on the CYP2D6 genotype have been developed. The CYP2D6 Screening Among Elderly (CYSCE) trial is designed to address the potential health and economic value of genotyping for CYP2D6 in optimizing dose-finding of nortriptyline and venlafaxine." />
<meta name="dc.source" content="Trials 2015 16:37" />
<meta name="dc.format" content="text/html" />
<meta name="dc.publisher" content="BioMed Central Ltd" />
<meta name="dc.date" content="2015-01-31" />
<meta name="dc.type" content="Study protocol" />
<meta name="dc.identifier" content="10.1186/s13063-015-0561-0" />
<meta name="dc.identifier" content="info:pmid/25636328" />
<meta name="dc.language" content="en" />
<meta name="dc.copyright" content="2015 Berm et al.; licensee BioMed Central." />
<meta name="dc.rights" content="http://creativecommons.org/licenses/by/2.0/" />
<meta name="dc.rightsAgent" content="reprints@biomedcentral.com" />

<meta name="prism.issn" content="1745-6215" />
<meta name="prism.publicationName" content="Trials" />
<meta name="prism.publicationDate" content="2015-01-31" />
<meta name="prism.volume" content="16" />
<meta name="prism.number" content="1" />
<meta name="prism.section" content="Study protocol" />
<meta name="prism.startingPage" content="37" />
<meta name="prism.copyright" content="2015 Berm et al.; licensee BioMed Central." />
<meta name="prism.rightsAgent" content="reprints@biomedcentral.com" />


        <meta name="citation_abstract_html_url" content="http://www.trialsjournal.com/content/16/1/37/abstract" />
            <meta name="citation_fulltext_html_url" content="http://www.trialsjournal.com/content/16/1/37" />
            <link rel='alternate' type='text/xml' title='XML version' href='http://www.trialsjournal.com/content/download/xml/s13063-015-0561-0.xml' />
            <link rel="image_src" href="http://www.trialsjournal.com/content/figures/s13063-015-0561-0-toc.gif" />
    
     <link rel="section" href="http://trialsjournal.com/content/download/supplementary/s13063-015-0561-0-s1.docx" title="Additional file 1:" />
    
    
                    
    

<script type="text/javascript">
// must run before css
document.documentElement.id = "js";
</script>



						
   
  
      
  
                  
  
                  
  
            
  
            
            



						
        <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery-1.8.2.min-0.js"></script>

	                <link rel="stylesheet" type="text/css" href="/css/main-0.css" media="screen, print"/>
    
                <link rel="stylesheet" type="text/css" href="/css/plugins-0.css" media="screen, print"/>
    



    

			                <link rel="stylesheet" type="text/css" href="http://www.bmcimg.com/css/articles-0.css" media="screen, print"/>
    	

    

    <link rel="stylesheet" type="text/css" href="/css/themes/10096.css" media="screen, print"/>


                <link rel="stylesheet" type="text/css" href="/css/media/print-0.css" media="print"/>
    



<!--[if IE]>
                    <link rel="stylesheet" type="text/css" href="/css/hacks/ie-0.css"/>
    <![endif]-->

<!--[if IE 7]>
                    <link rel="stylesheet" type="text/css" href="/css/hacks/ie7-0.css"/>
    <![endif]-->
			
<script type="text/javascript">
    //configuration
    OAS_url = '//oas.biomedcentral.com/RealMedia/ads/';

	// control of advert's position on page [AMC]
    
    	
	
    OAS_sitepage = "trialsjournal.com/article/10.1186/s13063/015/0561/0";
    	
		OAS_listpos = 'Top,x96,Right3';
	
	
			
		OAS_query = '';
		
	

    OAS_target = '_top';
    //end of configuration
    OAS_version = 10;
    OAS_rn = '001234567890'; OAS_rns = '1234567890';
    OAS_rn = new String (Math.random()); OAS_rns = OAS_rn.substring (2, 11);
    function OAS_NORMAL(pos) {
		document.write('<a href="' + OAS_url + 'click_nx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '!' + pos + '?' + OAS_query + '" target="' + OAS_target + '">');
		document.write('<img src="' + OAS_url + 'adstream_nx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '!' + pos + '?' + OAS_query + '" border="0"/></a>');
    }
    
	function refererTerms(referer) {

	if(referer.match("q=") != null) {
		referer = referer.split("q=");
		referer = referer[1].split("&");
		referer = referer[0];
	} else {
		referer = referer;
	}

		if(referer.match("%20") != null && referer.match("%20").length >= 1) {
			referer =  referer.replace(/%20/gi,"+");
			return referer;
		} else { 
			return referer; 
		}
	}
 </script>


 <script type="text/javascript">
	// Set the version of JavaScript to 10 for a Browser 'Mozilla/3' on webTV 
    OAS_version = 11;
    if ((navigator.userAgent.indexOf('Mozilla/3') != -1) || (navigator.userAgent.indexOf('Mozilla/4.0 WebTV') != -1)) {
     OAS_version = 10; }
    if (OAS_version >= 11) {
    document.write('<scr' + 'ipt type="text/javascript" src="' + OAS_url + 'adstream_mjx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '?' + OAS_query + '"><\/script>'); }
</script>
	
<script type="text/javascript">
    document.write('');
	
    function OAS_AD(pos) {
        if (OAS_version >= 11)
         OAS_RICH(pos);
        else
         OAS_NORMAL(pos);
    }
 </script>
	





<script type="text/javascript">
    jsonLoaders = function(){
        var _loaders = [];
        return {
            register: function(config){
                config.prefix = config.prefix || '/webapi/1.0/blogs/';
                config.feedLength = config.feedLength || 3;

                _loaders.push(config);
            },
            list: function(){return _loaders}
        };
    }();

    function totext() {
	    document.write('<a href="javascript:returnToText();">Return to text</a>');
    }

    function retrieve_doi(){
        var metas = document.getElementsByTagName('meta');
        var i;
        for (i = 0; i < metas.length; i++)
            if (metas[i].getAttribute('name') == "citation_doi")
                break;
        var citation_doi = metas[i].getAttribute('content');
        return citation_doi;
    }

</script>





    <script src="http://tjs.sjs.sinajs.cn/open/api/js/wb.js" type="text/javascript" charset="utf-8"></script>
        <link title="Latest articles" rel="alternate" href="http://www.trialsjournal.com/latest/rss" type="application/rss+xml" exposeToHeader="true"/>
    <link title="Most viewed" rel="alternate" href="http://www.trialsjournal.com/mostviewed/rss/" type="application/rss+xml" exposeToHeader="true"/>
    <link title="Latest comments" rel="alternate" href="http://www.trialsjournal.com/latestcomments/rss" type="application/rss+xml" exposeToHeader="true"/>
    


	<script type="text/javascript">
	var _gaq = _gaq || [];
	_gaq.push(['_setAccount', 'UA-9663741-5']);
	_gaq.push(['_gat._anonymizeIp']);
	_gaq.push(['_setLocalRemoteServerMode']);
	
	/*for cross domain tracking*/
	//_gaq.push(['_setAllowLinker', true]);
    //_gaq.push(['_setDomainName', 'trialsjournal.com']); //this journal's domain
	/**/
	
		_gaq.push(['_trackPageview']); 

	(function() {
		var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
		ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
		var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);

		//var iframe = document.getElementById('casesdb-search-widget');
		//if(iframe !== null) {
		//	var pageTracker = _gat._getTrackerByName();
		//	iframe.src = pageTracker._getLinkerUrl('http://www.casesdatabase.com/');
		//}
	})();
	</script>

	
        </head>


<body class=" theme    ">


        



   
  
      
  
                  
  
                  
  
            
  
            
            

    

<div id="oas-campaign" style="display:none">trialsjournal.com/article/10.1186/s13063/015/0561/0</div>
<div id="oas-positions" style="display:none">Bottom,Top</div>

<div id="branding" role="banner">
                			
		<dl class="google-ad wide ">
	<dt class="hide">
					<a class="banner-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising"></a>
				
			</dt>
		<dd>

		<!-- OAS AD 'Top' begin -->
		<script type="text/javascript">
		OAS_AD('Top');

		</script>
		<!-- OAS AD 'Top' end -->
		</dd>

		</dl>

		<noscript>
			<dl class="google-ad wide noscript">  
    <dt class="hide"></dt>
    
    <dd>
        <a href="//oas.biomedcentral.com/RealMedia/ads/click_nx.ads/trialsjournal.com/article/10.1186/s13063/015/0561/0/16900820479@Top?">
            <img src="//oas.biomedcentral.com/RealMedia/ads/adstream_nx.ads/trialsjournal.com/article/10.1186/s13063/015/0561/0/14704846438@Top?" alt="advert"/>
        </a>
    </dd>
			</dl>
		</noscript>
			            <div class="sup-panel-outer">
        <div class="sup-panel-inner">

            <style>
  #nojs li.greeting, #nojs li#loginLink {display:none;}
</style>


<ul id="login" class="login">

    <noscript><li><a href="/log"><img class="greeting" src="/images/log.gif"/></a></li></noscript>
    
    <li id="welcome"><span id="username"></span></li>

    <li id="loginLink"><a href=""></a></li>
    
    
</ul>

<script>

function login() {

/* cookie getter/setter */
var allCookies = {
  getItem: function (sKey) {
    if (!sKey || !this.hasItem(sKey)) { return null; }
    return unescape(document.cookie.replace(new RegExp("(?:^|.*;\\s*)" + escape(sKey).replace(/[\-\.\+\*]/g, "\\$&") + "\\s*\\=\\s*((?:[^;](?!;))*[^;]?).*"), "$1"));
  },
  setItem: function (sKey, sValue, vEnd, sPath, sDomain, bSecure) {
    if (!sKey || /^(?:expires|max\-age|path|domain|secure)$/i.test(sKey)) { return; }
    var sExpires = "";
    if (vEnd) {
      switch (vEnd.constructor) {
        case Number:
          sExpires = vEnd === Infinity ? "; expires=Tue, 19 Jan 2038 03:14:07 GMT" : "; max-age=" + vEnd;
          break;
        case String:
          sExpires = "; expires=" + vEnd;
          break;
        case Date:
          sExpires = "; expires=" + vEnd.toGMTString();
          break;
      }
    }
    document.cookie = escape(sKey) + "=" + escape(sValue) + sExpires + (sDomain ? "; domain=" + sDomain : "") + (sPath ? "; path=" + sPath : "") + (bSecure ? "; secure" : "");
  },
  removeItem: function (sKey, sPath) {
    if (!sKey || !this.hasItem(sKey)) { return; }
    document.cookie = escape(sKey) + "=; expires=Thu, 01 Jan 1970 00:00:00 GMT" + (sPath ? "; path=" + sPath : "");
  },
  hasItem: function (sKey) {
    return (new RegExp("(?:^|;\\s*)" + escape(sKey).replace(/[\-\.\+\*]/g, "\\$&") + "\\s*\\=")).test(document.cookie);
  },
  keys: /* optional method: you can safely remove it! */ function () {
    var aKeys = document.cookie.replace(/((?:^|\s*;)[^\=]+)(?=;|$)|^\s*|\s*(?:\=[^;]*)?(?:\1|$)/g, "").split(/\s*(?:\=[^;]*)?;\s*/);
    for (var nIdx = 0; nIdx < aKeys.length; nIdx++) { aKeys[nIdx] = unescape(aKeys[nIdx]); }
    return aKeys;
  }
};

// converts cookie into js object
function parseCookie(cookie) {

    cookie = cookie.split("&");
    var obj = {};

    for(var i = 0; i < cookie.length; i++) {

        var c = cookie[i].split("=");

        c[0] = c[0].replace('"','');
        
        obj[c[0]] = c[1];

    }
    return obj;
}

    var cookie = allCookies.getItem("bmccookie");

    var obj = (cookie != null) ? parseCookie(cookie) : {};
    

        var welcome = "";

        if(obj.hasOwnProperty("fname")) {

            // insert user welcome
            welcome = obj.fname.replace(/\+/g, " ") + " " + obj['lname'].replace(/\+/g," ");

            if(jQuery("#welcome").length > 0) {
              jQuery("#welcome").prepend("<strong>Welcome</strong> ");
              jQuery("#username").prepend('<strong>' + welcome + '</strong><span class="divider"></span>');
            } 

            // update link url
            jQuery("#loginLink a").text("Log off");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logoff");

            window.bmcloggedon = true;


        } else if(obj.hasOwnProperty("institution_name")) {

            // insert institution name
            welcome = obj["institution_name"].replace(/\+/g," ");
            
            if(jQuery("#welcome").length > 0) { 
                jQuery("#welcome").prepend("<strong>Welcome</strong> ");
                jQuery("#username").prepend('<strong>' + welcome + '</strong><span class="divider"></span>');
            } 

            // update link url
            jQuery("#loginLink a").text("Log on");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logon");

            window.bmcloggedon = false;


        } else {
            jQuery("#welcome").innerHTML = "";
            jQuery("#loginLink a").text("Log on");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logon");

            window.bmcloggedon = false;

        }


        // if athens login cookie doesn't exist and the athens login link is visible then remove it.
        if(allCookies.hasItem("athens") != true && document.getElementById("loginAthensLink") != null) {
          jQuery("#loginAthensLink").hide();
        }

}

login();


</script>

            <ul class="nav-sup">

    
        <li id="BMC" class="current">
            <a href="http://www.biomedcentral.com/"><span class="img-title">&nbsp;</span>
            <span class="text-title">BioMed Central</span></a>
        </li>
		
        		<li><a href="http://www.biomedcentral.com/journals"><span>Journals</span></a></li>
		
								<li>
				<a href="http://www.biomedcentral.com/gateways"><span>Gateways</span></a>
			</li>
					    	
</ul>
        </div>
    </div>
    <div class="branding-inner">

        

    
<style>
.survey {
	margin: 10px 0;
}
.survey, .survey .survey-sentence {
	font-size: 13px;
}
.survey-button a, .survey-button a:active, .survey-button a:visited, .survey-button a:hover  {
    color: #FFFFFF;
    text-decoration: none;
}
.survey-button {
	background-color: #FFA500;
    border-radius: 5px;
    color: #FFFFFF;
    font-weight: bold;
    font-size: 13px;
    font-weight: bold;
    padding: 5px 13px;
    background: #ef8142; /* Old browsers */
	background: -moz-linear-gradient(top,  #ef8142 0%, #ef8142 50%, #a64510 100%, #a64510 100%); /* FF3.6+ */
	background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,#ef8142), color-stop(50%,#ef8142), color-stop(100%,#a64510), color-stop(100%,#a64510)); /* Chrome,Safari4+ */
	background: -webkit-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* Chrome10+,Safari5.1+ */
	background: -o-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* Opera 11.10+ */
	background: -ms-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* IE10+ */
	background: linear-gradient(to bottom,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* W3C */
	filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#ef8142', endColorstr='#a64510',GradientType=0 ); /* IE6-9 */

}
</style>




          <div class="logo">
        <a href="/"><img alt="Trials" title="Trials Logo" src="/sites/10096/images/logo.gif" /></a>     
      </div>    
        
                    



            <div id="impact-factor" class="official">
    <img src="/images/branding/official.gif" alt="official impact factor" title="2.12"/>
    <span id="impact-factor-value">2.12</span>
</div>
    
                            

<div class="module search gray small  " role="search">
    <div class="module-inner padded">
        <form method="get" class="searchForm"
              action=" /quickSearchRedirectURL "
              onsubmit="window.location.href=this['url'].value + '?terms=' + encodeURIComponent(this['terms'].value); return false;">
            <fieldset class="search">
			                <span>
                    Search <select name="url">
                                <option value="http://www.trialsjournal.com/search/results" selected>Trials</option>
                                <option value="http://www.biomedcentral.com/search/results">BioMed Central</option>
                           </select> for
                </span>
                            <input id="searchTerms" name="terms" type="text" alt="Search terms" class="text " />
                 <button class="w37" value="Go" type="submit">Go</button>
            </fieldset>
        </form>
    </div>
	<a class="advanced-search" href="/search">Advanced search</a>
</div> 

                        <div id="mobile-nav-list" >

	<ul class="primary-nav" role="navigation">
		<li     ><a href="/"><span id="home-tab">Home</span></a></li>
														<li             class="current"
    ><a href="/content"><span id="articles-tab">Articles</span></a></li>
										
	

	
            <li     ><a href="/authors/instructions"><span id="authors-tab">Authors</span></a></li>
        <li     ><a href="/about/reviewers"><span id="reviewers-tab">Reviewers</span></a></li>
    		<li     ><a href="/about"><span id='about-tab'>About this journal</span></a></li>
	<li     ><a href="/my"><span id="my-tab">My Trials</span></a></li>
		
    		</ul>
</div>
            </div>
</div>

<hr class="hide" />
<div class="container">
	<div id="content"  class="overflow-visible"  role="main">
			    
	

<!--div class="branding-mobile">
		<h1 class="logo">
	    <a href="/">
		    <img alt="Trials" title="Trials Logo" src="/sites/10096/images/logo.gif" />
		</a>
		</h1>
	</div><br/-->



			
	



<div class="outline-wrapper block mobile-hidden" id="left-article-box">
<ul id="box-outline" class="box">
<ul id="outline" class="outline">
   <li>
      <a href="#">Top</a>
   </li>
   <li>
      <a href="#abs">Abstract</a>
   </li>
   <li>
      <a href="#sec1">Background</a>
   </li>
   <li>
      <a href="#sec2">Method/Design</a>
   </li>
   <li>
      <a href="#sec3">Discussion</a>
   </li>
   <li>
      <a href="#sec4">Trial status</a>
   </li>
   <li>
      <a href="#sec5">Abbreviations</a>
   </li>
   <li>
      <a href="#sec6">Competing interests</a>
   </li>
   <li>
      <a href="#sec7">Authors’ contributions</a>
   </li>
   <li class="long">
      <a href="#sec8" class="clipped" onmouseover="outlineover(this)" onmouseout="outlineout(this)" title="Additional file">Additional fi...</a>
   </li>
   <li>
      <a href="#ack">Acknowledgements</a>
   </li>
   <li class="lowest">
      <a href="#refs">References</a>
   </li>
</ul>
</ul>

<dl id="box-outline1">
</dl>

				



</div>



<div class="mobile-hidden" id="right-panel">
 	
<div id="mobile-sidebar">
	<div id="mobile-sidebar-tab">
		<span>
			<a href="#" id="mobile-sidebar-tab-link"><img src="/images/sidebar-hidden.png"><img style="display:none;" src="/images/sidebar-shown.png"></a>
		</span>
	</div>	<div id="mobile-sidebar-list">

<div id="article-navigation-bar">
    <div class="issue-information block">
        <h5><a href="http://www.trialsjournal.com"><strong>Trials</strong></a></h5>
 		        <ul class="square normal">
            <li><a href="http://www.trialsjournal.com/content/16">Volume 16</a></li>
				
                    </ul>
    </div>

    <div class="article-information block" id="article-info">
        


<div id="viewing-options-links">
	<h5>Viewing options</h5>
	<ul class="square normal">
        
            <li>
                             <a onclick="_gaq.push(['_trackEvent', 'Abstract', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="/content/16/1/37/abstract">Abstract</a>
                        </li>
        				<li>
							<strong>Full text</strong>
					</li>
				
		<li class="pdfFileSize">
			<a onclick="_gaq.push(['_trackEvent', 'PDF download', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="/content/pdf/s13063-015-0561-0.pdf">PDF</a>
			<span>(724KB)</span>
		</li>

        
				<li>
						<a onclick="_gaq.push(['_trackEvent', 'additional files', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="/content/16/1/37/additional">Additional files</a>
					</li>
			</ul>

        
</div>
		
<div id="associated-material-links">
    <h5>Associated material</h5>
    <ul class="square normal">
                        <li>
            <a onclick="_gaq.push(['_trackEvent', 'Pubmed record', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="/pubmed/25636328">PubMed record</a>
        </li>
                            <li><a onclick="_gaq.push(['_trackEvent', 'Article metrics', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="/content/16/1/37/about">Article metrics</a></li>
                <li>
                        <a onclick="_gaq.push(['_trackEvent', 'Readers comments', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="/content/16/1/37/comments">Readers' comments </a>
                    </li>
        <li>
                            <a onclick="_gaq.push(['_trackEvent', 'Pre-publication history', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="/content/16/1/37/prepub">Pre-publication history</a>                    </li>
    </ul>
</div>
		




<div id="related-literature-links">
    <h5>Related literature</h5>
    <ul class="normal">
                    <li><a onclick="_gaq.push(['_trackEvent', 'Citied by', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="http://www.trialsjournal.com/content/16/1/37/about#citations">Cited by</a></li>
                <li id="google-blog-search"><a onclick="_gaq.push(['_trackEvent', 'Google blog search', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="http://www.google.com/search?tbm=blg&hl=en&amp;source=hp&amp;biw=1280&amp;bih=899&amp;q=%22Effects+and+cost-effectiveness+of+pharmacogenetic+screening+for+CYP2D6+among+older+adults+starting+therapy+with+nortriptyline+or+venlafaxine%3A+study+protocol+for+a+pragmatic+randomized+controlled+trial+%28CYSCEtrial%29%22&amp;btnG=Search">Google blog search</a></li>
        <h6>Other articles by authors</h6>
        <li>
            <a class="collapser"><i>&nbsp;</i>on Google Scholar</a>
<ul id="authg" class="hidebeforeload">                         <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22EJJ+Berm%22">Berm EJJ</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22E+Hak%22">Hak E</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22M+Postma%22">Postma M</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22M+Boshuisen%22">Boshuisen M</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22L+Breuning%22">Breuning L</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22JRBJ+Brouwers%22">Brouwers JRBJ</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22T+Dhondt%22">Dhondt T</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22PAF+Jansen%22">Jansen PAF</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22RM+Kok%22">Kok RM</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22JG+Maring%22">Maring JG</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22R+van Marum%22">van Marum R</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22H+Mulder%22">Mulder H</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22RCO+Voshaar%22">Voshaar RCO</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22AJ+Risselada%22">Risselada AJ</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22H+Venema%22">Venema H</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22L+Vleugel%22">Vleugel L</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22B+Wilffert%22">Wilffert B</a>
            </li>
            </ul>          </li>
                <li>
            		<a class="collapser"><i>&nbsp;</i>on PubMed</a>
	<ul id="authpm" class="hidebeforeload"> 									<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Berm_EJJ%20[Author]">Berm EJJ</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Hak_E%20[Author]">Hak E</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Postma_M%20[Author]">Postma M</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Boshuisen_M%20[Author]">Boshuisen M</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Breuning_L%20[Author]">Breuning L</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Brouwers_JRBJ%20[Author]">Brouwers JRBJ</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Dhondt_T%20[Author]">Dhondt T</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Jansen_PAF%20[Author]">Jansen PAF</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Kok_RM%20[Author]">Kok RM</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Maring_JG%20[Author]">Maring JG</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=van_Marum_R%20[Author]">van Marum R</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Mulder_H%20[Author]">Mulder H</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Voshaar_RCO%20[Author]">Voshaar RCO</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Risselada_AJ%20[Author]">Risselada AJ</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Venema_H%20[Author]">Venema H</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Vleugel_L%20[Author]">Vleugel L</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Wilffert_B%20[Author]">Wilffert B</a>
				</li>
						</ul > 	        </li>
    </ul>     <h6>Related articles/pages</h6>
    <ul class="square normal">
        <li><a onclick="_gaq.push(['_trackEvent', 'on google', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="http://www.google.co.uk/search?hl=en&amp;q=related:http://www.trialsjournal.com/content/16/1/37">on Google</a></li>
        <li><a onclick="_gaq.push(['_trackEvent', 'on google scholar', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="http://scholar.google.com/scholar?q=related:http://www.trialsjournal.com/content/16/1/37">on Google Scholar</a></li>
                    <li><a onclick="_gaq.push(['_trackEvent', 'on Pubmed', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="/pubmed/related/25636328">on PubMed</a></li>
            </ul>

</div>		
        
    
    
        

    	






<h5>Tools</h5>
	<ul class="square normal">
									<li>
						<a onclick="_gaq.push(['_trackEvent', 'download references', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="/content/16/1/37/citation">Download references</a>
					</li>
				<li><a onclick="_gaq.push(['_trackEvent', 'download xml', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="/content/download/xml/s13063-015-0561-0.xml">Download XML</a></li>
				<li>
						<a onclick="_gaq.push(['_trackEvent', 'email2friend', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="/content/16/1/37/email">Email to a friend</a>
					</li>
		<li><a onclick="_gaq.push(['_trackEvent', 'order reprints', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=738&doi=10.1186/s13063-015-0561-0&volume=16&issue=1&title=Effects+and+cost-effectiveness+of+pharmacogenetic+screening+for+CYP2D6+among+older+adults+starting+therapy+with+nortriptyline+or+venlafaxine%3A+study+protocol+for+a+pragmatic+randomized+controlled+trial+%28CYSCEtrial%29&author_name=Elizabeth JJ Berm&start_page=1&end_page=8">Order reprints</a></li>
		<li>
						<a onclick="_gaq.push(['_trackEvent', 'post a comment', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="/content/16/1/37/postcomment">Post a comment</a>
					</li>			
		<ul id="download-to-links">
			<a class="downloadto_title btn" href="#"><span class="icon">&nbsp;</span>Download to ...</a>
			
			<ul id="downloadto" class="iconlist hidebeforeload" style="display: none;">
				<li>
					<a href="http://redirect.papersapp.com/redirect?url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F37" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Papers', 'Article Sidebar', '/content/16/1/37', 1, true]);"><span class="share-icons papers"></span>Papers</a>
				</li>
				<li>
					<a href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/37" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Mandeley', 'Article Sidebar', '/content/16/1/37', 1, true]);"><span class="share-icons mendeley"></span>Mendeley</a>
				</li>
			</ul>
		</ul>
		
		<ul id="mobile-downloadto" class="iconlist">
		
		<h6>Download to ...</h6>
			<li>
				<a href="http://redirect.papersapp.com/redirect?url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F37" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Papers', 'Article Sidebar', '/content/16/1/37', 1, true]);"><span class="share-icons papers"></span>Papers</a>
			</li>
			
			<li>
				<a href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/37" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Mandeley', 'Article Sidebar', '/content/16/1/37', 1, true]);"><span class="share-icons mendeley"></span>Mendeley</a>
			</li>
		</ul>

		
	</ul>
		




<h5>Share this article</h5>
<ul id="social-networking-links">
	<li>
	<div class="fb-like" onclick="_gaq.push(['_trackEvent', 'Facebook Recommend', 'Article Sidebar', '/content/16/1/37', 1, true]);" data-href="http://www.trialsjournal.com/content/16/1/37" data-send="false" data-layout="button_count" data-width="100" data-show-faces="false" data-action="recommend"></div>
	</li>
	<li>
		<a onclick="_gaq.push(['_trackEvent', 'Share Twitter Recommend', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="http://twitter.com/share" data-url="http://www.trialsjournal.com/content/16/1/37" data-counturl="http://www.trialsjournal.com/content/16/1/37" data-hashtags="trials
" data-text="Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial)" class="twitter-share-button">Tweet</a>
	</li>
	<li>
			<g:plusone size="medium" width="100"></g:plusone>
	</li>

        <li>
        <wb:share-button onclick="_gaq.push(['_trackEvent', 'Recommend Google plus', 'Article Sidebar', '/content/16/1/37', 1, true]);" addition="number" type="button" ralateUid="2216240737" title="Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial) http://www.trialsjournal.com/content/16/1/37"></wb:share-button>
    </li>
    
		<a class="sharethis_title btn" href="#"><span class="icon">&nbsp;</span>More options...</a>
	<ul class="iconlist hidebeforeload" id="sharethis">
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'citeu Like', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="http://www.citeulike.org/posturl?url=http://www.trialsjournal.com/content/16/1/37"><span class="share-icons citeulike"></span>Citeulike</a>
			</li>
				<li>
			<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share Linkedin', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="http://www.linkedin.com/shareArticle?mini=true&url=%26%2335%3Btrials%0D%0AEffects%20and%20cost-effectiveness%20of%20pharmacogenetic%20screening%20for%20CYP2D6%20among%20older%20adults%20starting%20therapy%20with%20nortriptyline%20or%20venlafaxine%3A%20study%20protocol%20for%20a%20pragmatic%20randomized%20controlled%20trial%20%28CYSCEtrial%29%20http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F37&title=Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial)"><span class="share-icons linkedin"></span>LinkedIn</a>
	</li>
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share delicious', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="http://del.icio.us/post?url=http://www.trialsjournal.com/content/16/1/37&title=Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial)"><span class="share-icons delicious"></span>Del.icio.us</a>
	</li>
			<li>
				<a onclick="_gaq.push(['_trackEvent', 'Share via email', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="/content/16/1/37/email"><span class="share-icons email"></span>Email</a>
	</li>
			<li>
				<a onclick="target="_blank" onclick="_gaq.push(['_trackEvent', 'Share facebook', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="http://www.facebook.com/sharer.php?u=http://www.trialsjournal.com/content/16/1/37"><span class="share-icons facebook"></span>Facebook</a>
	</li>
	<li class="gp">
			<div class="googlehider mobile-hide"> 
				<div class="g-plusone" data-annotation="none"></div>
			</div>
				<span class="share-icons googleplus mobile-hide"></span>
				<div class="googlehider2 mobile-hide"> 
				<div class="g-plusone mobile-hide" data-annotation="none"></div>
			</div>
				<span class="share-icons googleplus"></span>
				<span class="gp-link"><a  onclick="_gaq.push(['_trackEvent', 'Share google plus', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="#">Google+</a></span>
	</li>
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share Mandeley', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/37"><span class="share-icons mendeley"></span>Mendeley</a>
			</li>
			<li>
			<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share twitter icon', 'Article Sidebar', '/content/16/1/37', 1, true]);" href="http://twitter.com/?status=Effects%20and%20cost-effectiveness%20of%20pharmacogenetic%20screening%20for%20CYP2D6%20among%20older%20adults%20starting%20therapy%20with%20nortriptyline%20or%20venlafaxine%3A%20study%20protocol%20for%20a%20pragmatic%20randomized%20controlled%20trial%20%28CYSCEtrial%29%20http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F37+%23trials
"><span class="share-icons twitter"></span>Twitter</a>
			</li>

			<li><a href="http://www.reddit.com/submit" onclick="window.location = 'http://www.reddit.com/submit?url=http://www.trialsjournal.com/content/16/1/37'; return false"> <span class="share-icons reddit"></span>Reddit</a>
    </li>






		</ul>
</ul>

    </div>

    
  
        
                
        


















                                                                                
	

	    
   
  
      
  
                  
  
                  
  
            
  
            
            

<div id="signup-to-etoc" class="button-collection-margins block mobile-border-bottom">	
					<h3>Email updates</h3>
			<p id="receive_issue_alerts_journal_updates_text">Keep up to date with the latest news and content from Trials and BioMed Central.</p>
			
				
<form  id="articleSignupForUpdates"  method="post" action="/signuptoupdates.html">
	<div id="message-box"></div>
    <fieldset class="block-form">
        <input type="text" name="emailAddress" onblur="javascript: if (this.value == '') { this.value = 'email address'; }" onfocus="javascript: if (this.value == 'email address') { this.value = ''; }" value="email address"  class="text " id="email" />
        <input value="" type="hidden" name="returnUrl" id="returnUrl" />
        <input value="xniche-trials" type="hidden" name="listName" id="listName" />
        <input value="Trials" type="hidden" name="journalName" id="journalName" />
        <button onclick="_gaq.push('_trackEvent', 'Signup', 'Signup for Email updates', "Trials");" class="w74 right" type="submit" onmouseover="this.className='w74 hover right'" onmouseout="this.className='w74 right'" value="Sign up">Sign up</button>
    </fieldset>
</form>	
</div>

	


			<div id="advert-offset">
    					
		<dl class="google-ad  ">
	<dt class="hide">
				
					<a class="skyscraper-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</a>
			</dt>
		<dd>

		<!-- OAS AD 'Right3' begin -->
		<script type="text/javascript">
		OAS_AD('Right3');

		</script>
		<!-- OAS AD 'Right3' end -->
		</dd>

		</dl>

		<noscript>
			<dl class="google-ad  noscript">  
    <dt class="hide"><a href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</dt>
    
    <dd>
        <a href="//oas.biomedcentral.com/RealMedia/ads/click_nx.ads/trialsjournal.com/article/10.1186/s13063/015/0561/0/14945465511@Right3?">
            <img src="//oas.biomedcentral.com/RealMedia/ads/adstream_nx.ads/trialsjournal.com/article/10.1186/s13063/015/0561/0/16007103533@Right3?" alt="advert"/>
        </a>
    </dd>
			</dl>
		</noscript>
					</div>
	

	
</div>
		<div class="mobile-sidebar-gradient top"></div>
		<div class="mobile-sidebar-gradient bottom"></div>
	</div>

</div>








 </div>
<div class="rounded custom white article full-text">
<div class="wrap-inner content">
    <div class="padded-inner">            


    
   
  
      
  
                  
  
                  
  
            
  
            
            

<div id="topmatter">
	


	   






 
  



				<a href="/about/access"><img alt="Open Access" src="/images/articles/openaccess-large.png" class="access mr15"/></a>
					<span class="articletype">Study protocol</span>

<h1>Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial)</h1>
        
			<div class="multipleins">
		
	<p class="authors">
        																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										         <strong>Elizabeth JJ Berm</strong><sup><a href="/content/16/1/37/#ins1">1</a></sup>, <strong>Eelko Hak</strong><sup><a href="/content/16/1/37/#ins2">2</a></sup><sup><a href="/content/16/1/37/#ins3">3</a></sup>, <strong>Maarten Postma</strong><sup><a href="/content/16/1/37/#ins2">2</a></sup><sup><a href="/content/16/1/37/#ins3">3</a></sup>, <strong>Marjolein Boshuisen</strong><sup><a href="/content/16/1/37/#ins4">4</a></sup>, <strong>Laura Breuning</strong><sup><a href="/content/16/1/37/#ins5">5</a></sup>, <strong>Jacobus RBJ Brouwers</strong><sup><a href="/content/16/1/37/#ins1">1</a></sup><sup><a href="/content/16/1/37/#ins6">6</a></sup>, <strong>Ton Dhondt</strong><sup><a href="/content/16/1/37/#ins7">7</a></sup>, <strong>Paul AF Jansen</strong><sup><a href="/content/16/1/37/#ins6">6</a></sup>, <strong>Rob M Kok</strong><sup><a href="/content/16/1/37/#ins8">8</a></sup>, <strong>Jan G Maring</strong><sup><a href="/content/16/1/37/#ins9">9</a></sup>, <strong>Rob van Marum</strong><sup><a href="/content/16/1/37/#ins10">10</a></sup><sup><a href="/content/16/1/37/#ins11">11</a></sup>, <strong>Hans Mulder</strong><sup><a href="/content/16/1/37/#ins12">12</a></sup>, <strong>Richard C Oude Voshaar</strong><sup><a href="/content/16/1/37/#ins13">13</a></sup>, <strong>Arne J Risselada</strong><sup><a href="/content/16/1/37/#ins12">12</a></sup>, <strong>Harry Venema</strong><sup><a href="/content/16/1/37/#ins14">14</a></sup>, <strong>Liesbeth Vleugel</strong><sup><a href="/content/16/1/37/#ins15">15</a></sup> and <strong>Bob Wilffert</strong><sup><a href="/content/16/1/37/#ins1">1</a></sup><sup><a href="/content/16/1/37/#ins16">16</a></sup><sup>&#42;</sup>	</p>
	
				<div id="affiliations">
		<div class="module gray  inner">
<div class="module-inner padded-inner">
		<ul>
			<li>                                                                                                                                                                                                                        
                            		<p class="authors" >
							<span>*</span>
									 Corresponding author:										            Bob  Wilffert <a href='mailto:b.wilffert@rug.nl'>b.wilffert@rug.nl</a>    					</p>
      
</li>
			
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            		</ul>

		
		 <p class="options"><a class="affiliations-toggle" href="#"><i class="arrow"></i>Author Affiliations</a></p>            <section> 
						<div class="collapsible-content">
							
				<div id="ins_container" style="display: block;">
										    						    <p >
						        <sup id="ins1">1</sup>                                Groningen Institute of Pharmacy, University of Groningen, Unit of Pharmacotherapy & Pharmaceutical Care, Antonius Deusinglaan 1, Groningen, 9713AV, The Netherlands
                            </p>
																    						    <p >
						        <sup id="ins2">2</sup>                                Groningen Institute of Pharmacy, University of Groningen, Unit of Pharmacoepidemiology & Pharmacoeconomics, Groningen, The Netherlands
                            </p>
																    						    <p >
						        <sup id="ins3">3</sup>                                Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands
                            </p>
																    						    <p >
						        <sup id="ins4">4</sup>                                Lentis, Dignis, Groningen, The Netherlands
                            </p>
																    						    <p >
						        <sup id="ins5">5</sup>                                Departement of Old Age and Clinical Psychiatry, Reinier van Arkel Group, ‘s-Hertogenbosch, The Netherlands
                            </p>
																    						    <p >
						        <sup id="ins6">6</sup>                                Department of Geriatric Medicine and Expertise Centere Pharmacotherapy in Old Persons, UMC Utrecht, Utrecht, The Netherlands
                            </p>
																    						    <p >
						        <sup id="ins7">7</sup>                                Department of Old-age Psychiatry, GGZ-Noord Holland Noord, Heerhugowaard, The Netherlands
                            </p>
																    						    <p >
						        <sup id="ins8">8</sup>                                Department of Old Age, Parnassia Psychiatric Institute, The Hague, The Netherlands
                            </p>
																    						    <p >
						        <sup id="ins9">9</sup>                                Laboratory for Drug Analysis & Toxicology, Diaconessen Hospital Meppel & Bethesda Hospital Hoogeveen, Meppel, The Netherlands
                            </p>
																    						    <p >
						        <sup id="ins10">10</sup>                                Department of Geriatric Medicine, Jeroen Bosch Hospital, ‘s Hertogenbosch, The Netherlands
                            </p>
																    						    <p >
						        <sup id="ins11">11</sup>                                Department of General Practice & Elderly Care Medicine, VU University, Amsterdam, The Netherlands
                            </p>
																    						    <p >
						        <sup id="ins12">12</sup>                                Clinical Pharmacy, Wilhelmina Hospital Assen, Assen, The Netherlands
                            </p>
																    						    <p >
						        <sup id="ins13">13</sup>                                University of Groningen, University Medical Center Groningen, University Center for Psychiatry, Groningen, The Netherlands
                            </p>
																    						    <p >
						        <sup id="ins14">14</sup>                                Department of Old Age Psychiatry, GGZ Friesland, Leeuwarden, The Netherlands
                            </p>
																    						    <p >
						        <sup id="ins15">15</sup>                                Department of Old Age Psychiatry, GGZ inGeest, Haarlem, The Netherlands
                            </p>
																    						    <p >
						        <sup id="ins16">16</sup>                                Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands
                            </p>
																
				</div>
										<p id="authoremails">            For all author emails, please <a href="/logon">log on</a>.
    </p>
						</div>
			</section>
				</div>
</div>
		</div>
	  </div>

            <section class="cit">
                        <div class="collapsible-content">
        <p><em>Trials</em> 2015, <strong>16</strong>:37&nbsp;
			<span class="pseudotab">doi:10.1186/s13063-015-0561-0</span></p>
	    				    
    
        
                
		<p>The electronic version of this article is the complete one and can be found online at: <a href="http://www.trialsjournal.com/content/16/1/37">http://www.trialsjournal.com/content/16/1/37</a></p>
		<br/>
                    <table cellspacing="0" cellpadding="0">
        <tbody>
        <tr><td>Received:</td><td>15 October 2014</td></tr>                <tr><td>Accepted:</td><td>12 January 2015</td></tr>        <tr><td>Published:</td><td>31 January 2015</td></tr>        </tbody>
        </table>
    		<!--<br/>-->
		<div  style="line-height:140%">
        <p>
            &copy; 2015 Berm et al.; licensee BioMed Central. <br />
        </p>
					<p>
				This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href='http://creativecommons.org/licenses/by/4.0'>http://creativecommons.org/licenses/by/4.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
			</p>
		    	</div>
	</section>

</div>
<div id="article-body">
    <section><a name="abs"></a><h3>Abstract</h3>
   <div class="collapsible-content">
      <h4>Background</h4>
      <p style="line-height:160%">Nortriptyline and venlafaxine are commonly used antidepressants for treatment of depression
         in older patients. Both drugs are metabolized by the polymorphic cytochrome P450-2D6
         (CYP2D6) enzyme and guidelines for dose adaptations based on the <em>CYP2D6</em> genotype have been developed. The CYP2D6 Screening Among Elderly (CYSCE) trial is
         designed to address the potential health and economic value of genotyping for <em>CYP2D6</em> in optimizing dose-finding of nortriptyline and venlafaxine.
      </p>
      <h4>Methods/Design</h4>
      <p style="line-height:160%">In a pragmatic randomized controlled trial, patients diagnosed with a major depressive
         disorder according to the DSM-IV and aged 60&nbsp;years or older will be recruited from
         psychiatric centers across the Netherlands. After <em>CYP2D6</em> genotyping determined in peripheral blood obtained by finger-prick, patients will
         be grouped into poor, intermediate, extensive, or ultrarapid metabolizers. Patients
         with deviant genotype (that is poor, intermediate or ultrarapid genotype) will be
         randomly allocated to an intervention group in which the genotype and dosing advice
         is communicated to the treating physician, or to a control group in which patients
         receive care as usual. Additionally, an external reference group of patients with
         the extensive metabolizer genotype is included. Primary outcome in all groups is time
         needed to obtain an adequate blood level of the antidepressant drug. Secondary outcomes
         include adverse drug reactions measured by a shortened Antidepressant Side-Effects
         Checklist (ASEC), and cost-effectiveness of the screening.
      </p>
      <h4>Discussion</h4>
      <p style="line-height:160%">Results of this trial will guide policy-making with regard to pharmacogenetic screening
         prior to treatment with nortriptyline or venlafaxine among older patients with depression.
      </p>
      <h4>Trial registration</h4>
      <p style="line-height:160%">ClinicalTrials.gov: <a href="NCT01778907">NCT01778907</a> <a href="http://www.webcitation.org/query.php?url=NCT01778907&amp;refdoi=10.1186/s13063-015-0561-0" alt="" title="Archive copy of webpage" class="xpushbutton">webcite</a>; registration date: 22 January 2013.
      </p>
   </div>
</section><span id="keywords">
   <h5 class="inline">Keywords: </h5>CYP2D6; Pharmacogenetics; Depression; Nortriptyline; Venlafaxine</span><section><a name="sec1"></a><h3>Background</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">Depressive disorder is a chronic disease with a considerable impact on mental and
         physical health as well as quality of life <a name="d74959e336"></a>[<a onclick="LoadInParent('#B1'); return false;" href="#B1">1</a>]. The 1-month prevalence of major depressive disorder (MDD) in the Dutch population
         (aged 55 to 85&nbsp;years) is estimated around 2.0% <a name="d74959e340"></a>[<a onclick="LoadInParent('#B2'); return false;" href="#B2">2</a>]. From a meta-analysis (studies included from 1999 to 2009) a higher point prevalence
         estimation of 7.2 % has been reported for late life depression (75+ years) <a name="d74959e344"></a>[<a onclick="LoadInParent('#B3'); return false;" href="#B3">3</a>]. Among all mental diseases, MDD is ranked as a very disabling disease <a name="d74959e348"></a>[<a onclick="LoadInParent('#B4'); return false;" href="#B4">4</a>] and depressive disorders are projected to be the largest cause for disability by
         2030 in high-income countries <a name="d74959e352"></a>[<a onclick="LoadInParent('#B5'); return false;" href="#B5">5</a>].
      </p>
      <p style="line-height:160%">MDD can be treated with antidepressants, which are classified into different groups:
         selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressant (TCAs) and
         others (for example,. selective serotonin-noradrenaline reuptake inhibitors (SNRIs),
         mirtazapine, monoamine oxidase inhibitors). Although overall efficacy estimates are
         virtually similar between these drug groups, adverse drug profiles differ <a name="d74959e358"></a>[<a onclick="LoadInParent('#B6'); return false;" href="#B6">6</a>]. Worldwide, clinical guidelines usually advise first-step treatment with an SSRI
         because of a more favorable adverse effect profile compared to other antidepressants
         (for example, fewer cardiac side-effects and often lower drug anticholinergic side-effects)
         <a name="d74959e362"></a>[<a onclick="LoadInParent('#B7'); return false;" href="#B7">7</a>],<a name="d74959e366"></a>[<a onclick="LoadInParent('#B8'); return false;" href="#B8">8</a>]. If the chosen SSRI is not effective, switching to a TCA, preferably nortriptyline,
         or an SNRI, mostly venlafaxine, is an option <a name="d74959e370"></a>[<a onclick="LoadInParent('#B7'); return false;" href="#B7">7</a>].
      </p>
      <p style="line-height:160%">Venlafaxine and nortriptyline are both metabolized by the polymorphic cytochrome P450
         (CYP2D6) iso-enzyme <a name="d74959e376"></a>[<a onclick="LoadInParent('#B8'); return false;" href="#B8">8</a>]. Its polymorphic differences are generally classified into four different phenotypes:
         poor metabolizers (PM), intermediate metabolizers (IM), extensive metabolizers (EM),
         and ultrarapid metabolizers (UM). With respect to EM, PM and IM have a decreased enzymatic
         activity whereas UM have a higher activity, which is described in more depth elsewhere
         <a name="d74959e380"></a>[<a onclick="LoadInParent('#B9'); return false;" href="#B9">9</a>]. As a result of the variation in metabolizing capacity, as well as differences in
         gender, age, co-medication, and comorbidity among patients, different pharmacokinetics
         are observed <a name="d74959e384"></a>[<a onclick="LoadInParent('#B9'); return false;" href="#B9">9</a>],<a name="d74959e388"></a>[<a onclick="LoadInParent('#B10'); return false;" href="#B10">10</a>]. These differences can be monitored by therapeutic drug monitoring (TDM), which helps
         to find the right dosage for an individual patient. TDM of nortriptyline is ‘strongly
         recommended’ and for venlafaxine it is recommended especially during start of therapy
         <a name="d74959e392"></a>[<a onclick="LoadInParent('#B11'); return false;" href="#B11">11</a>]. Prior and in addition to TDM, information about the metabolic CYP2D6 activity could
         further improve this dose-finding. Since it is possible to detect polymorphic differences
         of <em>CYP2D6</em> based on genetic material, it is not dependent on the actual antidepressant intake
         (patient compliance) or collection time of the sample, like TDM samples are.
      </p>
      <p style="line-height:160%">For nortriptyline and venlafaxine genotyped-based dose adjustment guidelines have
         been formulated <a name="d74959e402"></a>[<a onclick="LoadInParent('#B10'); return false;" href="#B10">10</a>],<a name="d74959e406"></a>[<a onclick="LoadInParent('#B12'); return false;" href="#B12">12</a>],<a name="d74959e410"></a>[<a onclick="LoadInParent('#B13'); return false;" href="#B13">13</a>]. In the Netherlands, the Royal Dutch Pharmacist Association (KNMP) has made such
         guidelines available for current clinical practice <a name="d74959e414"></a>[<a onclick="LoadInParent('#B14'); return false;" href="#B14">14</a>],<a name="d74959e418"></a>[<a onclick="LoadInParent('#B15'); return false;" href="#B15">15</a>].
      </p>
      <p style="line-height:160%">Despite the large number of studies that assessed the relationship between pharmacogenetics
         and pharmacokinetics of antidepressants, implementation of pharmacogenetic knowledge
         into clinical practice is still scarce. The hypothesized clinical improvements facilitated
         by genotype-based dose adjustments in addition to current TDM, like improved efficacy
         and prevention of adverse drug reactions, are still a matter of controversy and discussion
         <a name="d74959e424"></a>[<a onclick="LoadInParent('#B16'); return false;" href="#B16">16</a>],<a name="d74959e428"></a>[<a onclick="LoadInParent('#B17'); return false;" href="#B17">17</a>]. There is a need to test this hypothesis in daily clinical practice. Therefore, we
         designed a pragmatic multicenter randomized controlled trial to determine the effects
         of a pharmacogenetic screening for <em>CYP2D6</em> on the time needed to obtain adequate blood levels of nortriptyline or venlafaxine.
         Since older persons are more vulnerable for adverse drug reactions, beneficial effects
         of genotype adjusted dosing are expected to be more apparent in this population. Therefore,
         the trial is conducted among older depressed patients starting with nortriptyline
         or venlafaxine. The cost-effectiveness of this screening will be assessed to support
         decision-making on the potential implementation of screening for <em>CYP2D6</em> genotype in daily clinical practice. The trial is designed to allow reporting according
         to the CONSORT guidelines <a name="d74959e438"></a>[<a onclick="LoadInParent('#B18'); return false;" href="#B18">18</a>].
      </p>
   </div>
</section>
<section><a name="sec2"></a><h3>Method/Design</h3>
   <div class="collapsible-content">
      <h4>Study design</h4>
      <p style="line-height:160%">The study is a multicenter randomized controlled trial across multiple old age psychiatry
         and geriatric mental health care institutions in the Netherlands. Patients will be
         recruited by their treating physician or a specialized trial nurse. The study consists
         of two parts and for both parts separate written informed consent will be obtained.
         The first part is a basic genotype screening study in which each eligible patient
         (see description in Participants below) starting with nortriptyline or venlafaxine
         will be asked permission for genotyping. Patients with a PM, IM and UM genotype will
         be selected for participation in the second (trial) part of the study. After giving
         the second informed consent, the trial entails a follow-up period of 6&nbsp;weeks or longer
         in order to monitor the blood levels and adverse reactions of either nortriptyline
         or venlafaxine. A random selection of patients with an EM genotype will be allocated
         to an additional reference group (Figure&nbsp;<a name="d74959e451"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/37/figure/F1','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/37/figure/F1">1</a>). Recruitment is expected to be completed within approximately 3&nbsp;years. If selected
         for the trial part of the study, eligible patients are invited for a baseline visit.
         At baseline, 2&nbsp;weeks, and 4&nbsp;weeks after baseline blood samples are collected to estimate
         the blood level of the drug by a ‘Dried Blood Spot’ (DBS) method. Additionally, questionnaires
         concerning adverse drug reactions, quality of life, productivity and health care use,
         and severity of depression are completed. Patients who do not complete dose-finding
         after 6&nbsp;weeks will be followed for additional 2-week measurements until dose-finding
         is completed. These additional 2-week samples will be collected only for those patients
         who had a dose change 3&nbsp;weeks or less prior to the moment the sample was collected,
         since it can take up to 2 to 3&nbsp;weeks for PMs of nortriptyline to reach steady state
         concentration <a name="d74959e455"></a>[<a onclick="LoadInParent('#B19'); return false;" href="#B19">19</a>]. When the follow-up period is finished for an individual patient, the genotype information
         will be supplied to the treating physician. Ethical approval was obtained by an Independent
         Ethics Committee (RTPO-Leeuwarden-NL; file number: NL40925.099.12) and the study will
         be conducted in accordance with the Declaration of Helsinki.
         
      </p><div class="figs">
      <div class="fig"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/37/figure/F1','F1',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/37/figure/F1"><img align="top" src="/content/figures/s13063-015-0561-0-1.gif" alt="thumbnail" class="thumbnail"><strong>Figure 1.</strong></a> <strong>Flowchart for inclusion of patients.</strong></div></div>
      <h4>Participants</h4>
      <p style="line-height:160%">Patients 60&nbsp;years or older and diagnosed with a major depression according to the
         <em>Diagnostic and Statistical Manual of Mental Disorders, fourth edition text revision</em> (DSM-IV TR) <a name="d74959e480"></a>[<a onclick="LoadInParent('#B20'); return false;" href="#B20">20</a>], criteria (code: 296.2x or 296.3x) diagnosed by the treating physician, are eligible
         for inclusion. Patients should be starting with either nortriptyline or venlafaxine
         and competent to understand the two separate informed consent procedures. Patients
         with known liver cell damage, which in clinical practice often serves as a proxy for
         a poor hepatic function (aspartate aminotransferase and alanine aminotransferase (ASAT/ALAT)
         or gamma-glutamyl transferase (γ-GT) ≥ twice the maximal reference value), impaired
         renal function (eGFR &lt; 30&nbsp;mL/minute) in combination with venlafaxine use, or currently
         using drugs influencing blood levels of nortriptyline or venlafaxine are excluded
         for trial participation. Patients using terbinafine, ketoconazole, voriconazole, kinidine,
         propafenon, cimetidine, fluoxetine, paroxetine, bupropion, duloxetine, sertraline,
         abirateron, cinacalcet, rifampicine, and ritanovir are excluded for trial participation.
         For these drugs, interactions can be expected based on pharmacy interaction monitoring
         software (G-standaard, Z-index BV, The Hague, The Netherlands), summary of product
         characteristics, and Flockhart’s interaction table <a name="d74959e484"></a>[<a onclick="LoadInParent('#B21'); return false;" href="#B21">21</a>].
      </p>
      <h4><em>CYP2D6</em> genotyping
      </h4>
      <p style="line-height:160%">In the first part of the study, a DBS sample for genotyping will be taken at the time
         of prescription of nortriptyline or venlafaxine by means of a finger-prick <a name="d74959e496"></a>[<a onclick="LoadInParent('#B22'); return false;" href="#B22">22</a>]. The sample will be sent to the Pharmacogenetic lab of the Wilhelmina Hospital Assen
         (Assen, the Netherlands), for analysis. Single nuclear polymorphism (SNPs) will be
         assessed for the *3, *4, *5, *6, *10, *17, *41 alleles, as well as duplications of
         the <em>CYP2D6</em> gene. Presence of an allele that completely lacks enzyme activity (*3, *4, *5, *6
         ) paired with another allele completely lacking enzyme activity results in a PM phenotype
         prediction and in an IM phenotype prediction if paired with an allele with decreased
         enzyme activity (*10, *17, *41). Presence of only one allele lacking enzyme activity,
         or two alleles with decreased enzyme activity also results in an IM phenotype prediction.
         Duplications of the <em>CYP2D6</em> gene results in an UM phenotype prediction unless it is combined with any allele
         with reduced or lacking enzyme activity. Duplications combined with any allele with
         reduced or lacking enzyme activity results in exclusion of the patient from follow-up
         because no adequate dosing advice can be given for these genotypes. After inclusion,
         genotype information will be available for randomization within 6 to 9&nbsp;days.
      </p>
      <h4>Baseline</h4>
      <p style="line-height:160%">Baseline assessment will include a severity of depression score measured by the Montgomery-Asberg
         Depression Rating Scale and measurement of symptoms which are followed-up as adverse
         events during the further trial <a name="d74959e512"></a>[<a onclick="LoadInParent('#B23'); return false;" href="#B23">23</a>]. In addition, comorbidities and drug use other than nortriptyline and venlafaxine
         will be collected by the Short Form Health and Labor Questionnaire <a name="d74959e516"></a>[<a onclick="LoadInParent('#B24'); return false;" href="#B24">24</a>].
      </p>
      <h4>Randomization and allocation</h4>
      <p style="line-height:160%">After the genotype is determined, patients with a PM, IM, or UM genotype are selected
         and randomly allocated by computer to the ‘deviating genotype-intervention arm’ (DG-I)
         or ‘deviating genotype-control arm’ (DG-C) for participation in the main study (Figure&nbsp;<a name="d74959e525"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/37/figure/F1','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/37/figure/F1">1</a>). An additional sample of patients with the EM genotype is allocated to a third ‘normal
         genotype- control’ arm (NG-C). The PM, IM and UM genotypes for <em>CYP2D6</em> are expected to be found in approximately 30% of the population <a name="d74959e532"></a>[<a onclick="LoadInParent('#B9'); return false;" href="#B9">9</a>]. Therefore, it is expected that patients with the EM genotype will be found more
         frequently than patients with a deviating genotype. To prevent any potential time-dependent
         bias, the selection of patients with an EM genotype allocated to the NG-C arm is dependent
         on the number of patients in the other trial arms.
      </p>
      <h4>Deviating genotype-intervention arm (DG-I)</h4>
      <p style="line-height:160%">The DG-I arm includes patients with a PM, IM, or UM genotype. The specific genotype
         accompanied by dosing advice is directly communicated to the treating physician. This
         should preferably take place 14&nbsp;days after inclusion. The dosing advice is based on
         the genotype and drug only, meaning some standard advice depending on these two variables
         is given by an automatically generated message (see Additional file <a name="d74959e541"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/37/suppl/S1','',630,470); return false;" href="http://www.trialsjournal.com/content/16/1/37/suppl/S1">1</a>).
      </p>
      <h4>Deviating genotype-control arm (DG-C) and normal genotype-control arm (NG-C)</h4>
      <p style="line-height:160%">The DG-C arm includes patients with a deviating genotype and the NG-C arm will include
         patients with a normal genotype. In contrast to patients in the intervention arm,
         the treating physician will not be informed about the genotype of patients in one
         of the control arms. Although methodologically there is a different approach for deviating
         and normal genotype patients, for the physician, patients will appears as one control
         group. This ensures that patients in the control group can have any genotype as in
         the normal population.
      </p>
      <h4>Outcomes</h4>
      <h4>Primary outcome</h4>
      <p style="line-height:160%">Primary outcome will be the time needed to reach adequate blood levels of nortriptyline
         or venlafaxine, which will be determined by a DBS sample <a name="d74959e561"></a>[<a onclick="LoadInParent('#B25'); return false;" href="#B25">25</a>],<a name="d74959e565"></a>[<a onclick="LoadInParent('#B26'); return false;" href="#B26">26</a>]. The use of DBS for therapeutic drug monitoring is described in more depth elsewhere
         <a name="d74959e569"></a>[<a onclick="LoadInParent('#B27'); return false;" href="#B27">27</a>]. Blood samples will be sent to the Laboratory for Drug Analysis &amp; Toxicology of the
         Diaconessen Hospital (Meppel, the Netherlands). Advised therapeutic ranges follow
         the current Dutch Clinical Pharmacy guidelines (NVZA), indicating for nortriptyline
         levels between 50 to 150&nbsp;μg/L and for venlafaxine + O-desmethylvenlafaxine between
         100 to 400&nbsp;μg/L. We defined adequate drug levels as <a name="d74959e573"></a>[<a onclick="LoadInParent('#B1'); return false;" href="#B1">1</a>] being within the therapeutic range and <a name="d74959e577"></a>[<a onclick="LoadInParent('#B2'); return false;" href="#B2">2</a>] no dose changes during the previous 3&nbsp;weeks.
      </p>
      <h4>Secondary outcome</h4>
      <p style="line-height:160%">Secondary outcomes will be adverse drug reactions measured by a shorter and modified
         version of the Antidepressant Side-Effect Checklist (ASEC) <a name="d74959e587"></a>[<a onclick="LoadInParent('#B28'); return false;" href="#B28">28</a>], quality of life measured by the EuroQol 5D (EQ5D) <a name="d74959e591"></a>[<a onclick="LoadInParent('#B29'); return false;" href="#B29">29</a>], and productivity and cost of health care use measured by the Trimbos/iMTA questionnaire
         for Cost associated with Psychiatric Illness (TiC-P) <a name="d74959e595"></a>[<a onclick="LoadInParent('#B24'); return false;" href="#B24">24</a>]. Severity of depression will be measured to control for possible differences between
         groups related to the severity of depression instead of the genotype-based intervention,
         by the Quick Inventory of Depressive Symptomatology Self-Reported Questionnaire (QIDS-SR)
         <a name="d74959e599"></a>[<a onclick="LoadInParent('#B30'); return false;" href="#B30">30</a>]. Secondary outcomes will all be measured by a telephone interview from baseline till
         endpoint, every 2&nbsp;weeks, except for the side-effects. Side-effects will be assessed
         by the treating physician and will additionally be collected before start of the treatment.
         In this way we will be able to correct for symptoms of depression or other underlying
         physical diseases, which are often perceived by the patient as side-effects of the
         antidepressant <a name="d74959e603"></a>[<a onclick="LoadInParent('#B28'); return false;" href="#B28">28</a>].
      </p>
      <h4>Sample size calculation</h4>
      <p style="line-height:160%">Based on clinical experience in the research setting it is expected that on average
         it takes 4&nbsp;weeks for patients with a deviating genotype to reach adequate serum drug
         levels. It is hypothesized that time to reach adequate levels will be reduced by 50%
         (2&nbsp;weeks) if we provide the screening information to the physician within 6 to 9&nbsp;days.
         To obtain 90% power to detect a 50% reduction from 4 to 2&nbsp;weeks (SD 3&nbsp;weeks) with
         a type-1 error of 2.5% to account for multiple testing (within trial and externaltrial),
         a minimum of 48 patients per arm is needed. To account for loss to follow-up we intend
         to include at least 75 patients per arm.
      </p>
      <h4>Statistical analysis and report</h4>
      <p style="line-height:160%">Reporting and analysis of the data from this trial will be in accordance with the
         CONSORT 2010 guidelines <a name="d74959e619"></a>[<a onclick="LoadInParent('#B18'); return false;" href="#B18">18</a>].
      </p>
      <h4>Baseline</h4>
      <p style="line-height:160%">Baseline characteristics will be presented using descriptive statistics including
         means or medians for continuous variables and percentages for categorical variables.
         Analytical statistics to estimate difference between the group of patients who were
         lost to follow-up versus patients who completed the trial as well as between the different
         study arms will be determined by <em>t</em>-tests or non-parametric alternatives for continuous variables and Chi-square tests
         for categorical variables.
      </p>
      <h4>Primary analysis</h4>
      <p style="line-height:160%">The primary analysis will assess the mean time needed to obtain adequate drug levels.
         The first time drug blood levels are within the therapeutic range and dose is not
         increased or decreased in the following 3&nbsp;weeks is the moment that is considered as
         the time needed to obtain adequate drug levels. Mean differences in time to reach
         adequate drug levels between trial groups will be estimated using the <em>t</em>-test or a non-parametric alternative if not normally distributed. Analysis of variance
         (ANOVA) or Kruskal-Wallis test will be applied to test for potential differences between
         the trial groups and the external reference group.
      </p>
      <h4>Secondary analyses</h4>
      <p style="line-height:160%">Secondary analysis will focus on statistical differences in median number and severity
         scores of side-effects of the drug. Since the side-effect profile is different for
         nortriptyline and venlafaxine, these analyses will be drug-specific.
      </p>
      <h4>Cost-effectiveness analyses</h4>
      <p style="line-height:160%">Effects and costs will be determined from a societal perspective including both indirect
         and direct costs. Data on health care associated resource use will be collected and
         effects on productivity and quality of life (EQ5D) will be investigated. To determine
         the incremental cost-effectiveness ratio for intervention versus control strategy
         from a societal perspective, guideline unit costs will be linked to these resource
         use data. Incremental cost-effectiveness will be calculated using state-of-the-art
         methods including uncertainty analysis (bootstrapping, Fieller’s estimates), scenario
         analysis, (probabilistic) sensitivity analysis and presentation in cost-effectiveness
         acceptability curves.
      </p>
   </div>
</section>
<section><a name="sec3"></a><h3>Discussion</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">To the best of our knowledge, this is the first pragmatic randomized controlled trial
         designed to test whether <em>CYP2D6</em> polymorphism genotyping among older depressed patients starting with nortriptyline
         or venlafaxine in clinical practice adds value to regular care. Results of this trial
         will generate evidence as to whether routinely-based genotype testing can reduce the
         time needed for dose-finding at the start of treatment and as a result reduce adverse
         drug reactions.
      </p>
      <p style="line-height:160%">A possible limitation of this study is that the genotype information is given to the
         physician after treatment with the antidepressant has already been started for several
         days. For the purpose of this trial, it would be ideal to give the genotype information
         before treatment has started. However, in clinical practice due to the urgency of
         the disease, time between initiating a therapy with nortriptyline or venlafaxine and
         actual start is limited. Waiting for the genotype information before starting pharmacotherapy
         could delay pharmacotherapy and is, therefore, unwanted. Nevertheless, an effect of
         genotype is still expected, because at start of treatment a low dose is generally
         prescribed. When the treating physician has to evaluate therapy and to decide if the
         dosage should be increased, the genotype information will be available <a name="d74959e664"></a>[<a onclick="LoadInParent('#B31'); return false;" href="#B31">31</a>].
      </p>
      <p style="line-height:160%">Another limitation of this study is the study domain represented by a heterogeneous
         group of severely depressed patients, since the disease shows much variation in symptomatology,
         severity and co-existing psychiatric diseases like anxiety disorders and physical
         diseases, especially in secondary care <a name="d74959e670"></a>[<a onclick="LoadInParent('#B32'); return false;" href="#B32">32</a>]. However, a strict selection of patients who suffer from depression without the presence
         of certain comorbid physical or psychiatric disorders would exclude a lot of patients
         from this study and limit applicability of the results to daily practice. Therefore,
         inclusion is not limited by severity of depression, co-existing psychiatric diseases
         or other comorbidities. This is a common characteristic of pragmatic trials and gives
         results which are better generalizable to actual clinical practice <a name="d74959e674"></a>[<a onclick="LoadInParent('#B33'); return false;" href="#B33">33</a>].
      </p>
      <p style="line-height:160%">Furthermore, the drug concentration-effect relationship for venlafaxine is still a
         subject of debate <a name="d74959e680"></a>[<a onclick="LoadInParent('#B34'); return false;" href="#B34">34</a>]. This is illustrated by different advised therapeutic windows. Some refer to a therapeutic
         window between 250 to 750&nbsp;μg/L, whereas recent guidelines advice a therapeutic window
         between 100 to 400&nbsp;μg/L, which is also incorporated in current Dutch guidelines <a name="d74959e684"></a>[<a onclick="LoadInParent('#B11'); return false;" href="#B11">11</a>],<a name="d74959e688"></a>[<a onclick="LoadInParent('#B35'); return false;" href="#B35">35</a>]. Nevertheless, current guidelines advise a smaller therapeutic window, indicating
         the need for a more accurate drug dosing. To facilitate this, genotyping may play
         an important role.
      </p>
      <p style="line-height:160%">Strengths of this study are the random allocation of subjects to receive genetic information
         that avoids incomparability of groups, strict protocolled design with regular measurements,
         and a large number of patients to detect statistically significant differences. We
         also included an external control arm (NG-C) including patients with the EM genotype.
         This ensures physicians do not know the genotype of control patients or that it deviates
         from EM.
      </p>
      <p style="line-height:160%">The overall impact of <em>CYP2D6</em> screening may be underestimated in this trial, since the genotype is a lifelong characteristic
         and is, therefore, affecting the metabolism of many other drugs than the drugs studied
         in this trial. We only look at a short drug-specific time effect in this study; however,
         it is not unlikely that patients might benefit from their genotype information during
         further pharmacotherapy.
      </p>
   </div>
</section>
<section><a name="sec4"></a><h3>Trial status</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">The recruitment of patients started in spring 2013 and is expected to continue until
         spring 2016.
      </p>
   </div>
</section>
<section><a name="sec5"></a><h3>Abbreviations</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">ALT: alanine aminotransferase</p>
      <p style="line-height:160%">ANOVA: analysis of variance</p>
      <p style="line-height:160%">ASEC: Antidepressants Side-Effect Checklist</p>
      <p style="line-height:160%">AST: aspartate aminotransferase</p>
      <p style="line-height:160%">DBS: Dried Blood Spot</p>
      <p style="line-height:160%">DG-C: deviating genotype control</p>
      <p style="line-height:160%">DG-I: deviating genotype intervention</p>
      <p style="line-height:160%">DSM: 
         <em>Diagnostic and Statistical Manual of Mental Disorders</em></p>
      <p style="line-height:160%">EQ5D: EuroQol 5D quality of life quesionnaire</p>
      <p style="line-height:160%">EM: extensive metabolizer</p>
      <p style="line-height:160%">γGT: gamma-glutamyl transferase</p>
      <p style="line-height:160%">IM: intermediate metabolizer</p>
      <p style="line-height:160%">KNMP: Royal Dutch Pharmacist Association</p>
      <p style="line-height:160%">NG-EC: normal genotype-external control</p>
      <p style="line-height:160%">MDD: major depressive disorder</p>
      <p style="line-height:160%">NVZA: Dutch Clinical Pharmacy guidelines</p>
      <p style="line-height:160%">PM: poor metabolizer</p>
      <p style="line-height:160%">QIDS-SR: Quick Inventory of Depressive Symptomatology Self-Reported Questionnaire</p>
      <p style="line-height:160%">SNRI: selective serotonin-noradrenaline reuptake inhibitor</p>
      <p style="line-height:160%">SSRI: selective serotonin reuptake inhibitor</p>
      <p style="line-height:160%">SNP: single nuclear polymorphism</p>
      <p style="line-height:160%">TCA: tricyclic antidepressant</p>
      <p style="line-height:160%">TiC-P: Cost associated with Psychiatric Illness</p>
      <p style="line-height:160%">TDM: therapeutic drug monitoring</p>
      <p style="line-height:160%">UM: ultrarapid metabolizer</p>
   </div>
</section>
<section><a name="sec6"></a><h3>Competing interests</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">The authors declare that they have no competing interests.</p>
   </div>
</section>
<section><a name="sec7"></a><h3>Authors’ contributions</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">EB, EH, MP, MB, LB, JB, TD, PJ, RK, JGM, RvM, HM, ROV, AR, HV, LV, and BW designed
         the study. EH contributed to the sample size calculation and statistical analysis.
         EB, EH and BW made two amendments to the first protocol. HM and AR facilitate the
         genotyping and JGM the determination of venlafaxine or nortriptyline in the blood
         samples. EB, HM, AR and BW wrote the standardized advice based on the genotype and
         existing guidelines for the intervention group (see Additional file <a name="d74959e774"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/37/suppl/S1','',630,470); return false;" href="http://www.trialsjournal.com/content/16/1/37/suppl/S1">1</a>). EB drafted the manuscript, which was critically revised by EH, JB and BW. MB, LB,
         TD, RK, RvM, ROV, HV and LV coordinate enrollment of patients at clinical centers.
         All authors read and approved the final version of the manuscript.
      </p>
   </div>
</section>
<section><a name="sec8"></a><h3>Additional file</h3>
   <div class="collapsible-content"><div class="figs">
      <div class="addfile"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/37/suppl/S1','S1',630,470); return false;" href="http://www.trialsjournal.com/content/16/1/37/suppl/S1"></a><strong>Additional file 1:.</strong> <strong>Advice based on the Dutch KNMP’s pharmacogenetic guidelines, specified for this specific
            study purpose with the help of experts in the field.</strong> Description: this file contains the advice that was communicated to the treating
         physicians during the study period.</p><p>
         	Format: DOCX 
         	Size: 18KB <a href="/content/supplementary/s13063-015-0561-0-s1.docx">Download file</a><span class="open-data-icon"><a href="/about/access/#opendata"><img title="Open Data" alt="Open Data" src="/bmcimages/article/opendata.gif"></a></span></div></div>
   </div>
</section>
<section><a name="ack"></a><h3>Acknowledgements</h3>
   <div class="collapsible-content">
      <p style="line-height:160%"><em>Funding</em></p>
      <p style="line-height:160%">This study was funded by a grant from ‘Netherlands Organization for Health Research
         and Development (ZonMw, project number: 113102002) as a part of the ‘Priority Medicines
         in Elderly Program’. We acknowledge the work by Inge van Doornik, MSc, in supporting
         the organization of the logistics and implementation of the trial. We thank René Schutte,
         Ellen Brummel-Mulder, and Jolanda Paardekooper for their help in organizing the laboratory
         facilities during the trial.
      </p>
   </div>
</section>
<section><a name="refs"></a><h3>References</h3>
   <div id="article-references" class="collapsible-content">
      <ol id="references">
         <li id="B1">
            <p><a name="B1"></a> Brown PJ,  Roose SP: <strong> Age and anxiety and depressive symptoms: the effect on domains of quality of life. </strong><p><em>Int J Geriatr Psychiatry</em> 2011,  <strong>26</strong>(12)<strong>:</strong>1260-6.  <a target="_blank" href="/pubmed/21351152">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21351152">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B1" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B1','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B2">
            <p><a name="B2"></a> Beekman AT,  Copeland JR,  Prince MJ: <strong> Review of community prevalence of depression in later life. </strong><p><em>Br J Psychiatry</em> 1999,  <strong>174</strong><strong>:</strong>307-11.  <a target="_blank" href="/pubmed/10533549">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=10533549">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B2" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B2','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B3">
            <p><a name="B3"></a> Luppa M,  Sikorski C,  Luck T,  Ehreke L,  Konnopka A,  Wiese B, <em>et al</em>.: <strong> Age- and gender-specific prevalence of depression in latest-life - systematic review
                  and meta-analysis. </strong><p><em>J Affect Disord</em> 2012,  <strong>136</strong>(3)<strong>:</strong>212-21.  <a target="_blank" href="/pubmed/21194754">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21194754">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B3" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B3','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B4">
            <p><a name="B4"></a> Murray CJ,  Vos T,  Lozano R,  Naghavi M,  Flaxman AD,  Michaud C, <em>et al</em>.: <strong> Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions,
                  1990–2010: a systematic analysis for the global burden of disease study 2010. </strong><p><em>Lancet</em> 2012,  <strong>380</strong>(9859)<strong>:</strong>2197-223.  <a target="_blank" href="/pubmed/23245608">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=23245608">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B4" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B4','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B5">
            <p><a name="B5"></a> Mathers CD,  Loncar D: <strong> Projections of global mortality and burden of disease from 2002 to 2030. </strong><p><em>PLoS Med</em> 2006,  <strong>3</strong>(11)<strong>:</strong>e442.  <a target="_blank" href="/pubmed/17132052">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=17132052">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B5" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B5','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B6">
            <p><a name="B6"></a> Kok RM,  Nolen WA,  Heeren TJ: <strong> Efficacy of treatment in older depressed patients: a systematic review and meta-analysis
                  of double-blind randomized controlled trials with antidepressants. </strong><p><em>J Affect Disord</em> 2012,  <strong>141</strong>(2–3)<strong>:</strong>103-15.  <a target="_blank" href="/pubmed/22480823">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=22480823">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B6" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B6','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B7">
            <p><a name="B7"></a>Reuben D, Herr K, Pacala J, Pollock B, Potter J, Semla T. Depression. Geriatrics at
               your fingertips. 16th ed. American Geriatrics Society; 2014.
            </p>
         </li>
         <li id="B8">
            <p><a name="B8"></a>Landelijke stuurgroep multidiciplinaire richtlijnontwikkeling in de GGZ. Dutch Guideline
               Depression (Addendum Elderly) Addendum Ouderen bij MDR derpessie. 2008.
            </p>
         </li>
         <li id="B9">
            <p><a name="B9"></a> Ingelman-Sundberg M: <strong> Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary
                  aspects and functional diversity. </strong><p><em>Pharmacogenomics J</em> 2005,  <strong>5</strong>(1)<strong>:</strong>6-13.  <a target="_blank" href="/pubmed/15492763">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=15492763">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B9" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B9','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B10">
            <p><a name="B10"></a> Kirchheiner J,  Nickchen K,  Bauer M,  Wong ML,  Licinio J,  Roots I, <em>et al</em>.: <strong> Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic
                  variations to the phenotype of drug response. </strong><p><em>Mol Psychiatry</em> 2004,  <strong>9</strong>(5)<strong>:</strong>442-73.  <a target="_blank" href="/pubmed/15037866">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=15037866">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B10" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B10','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B11">
            <p><a name="B11"></a> Hiemke C,  Baumann P,  Bergemann N,  Conca A,  Dietmaier O,  Egberts K, <em>et al</em>.: <strong> AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. </strong><p><em>Pharmacopsychiatry</em> 2011,  <strong>44</strong>(6)<strong>:</strong>195-235.   <a target="_blank" href="http://dx.doi.org/10.1055/s-0031-1286287">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B11" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B11','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B12">
            <p><a name="B12"></a> de Leon J,  Armstrong SC,  Cozza KL: <strong> Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450
                  2D6 and CYP450 2C19. </strong><p><em>Psychosomatics</em> 2006,  <strong>47</strong>(1)<strong>:</strong>75-85.  <a target="_blank" href="/pubmed/16384813">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=16384813">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B12" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B12','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B13">
            <p><a name="B13"></a>Hicks JK, Swen JJ, Thorn CF, Sangkuhl K, Kharasch ED, Ellingrod VL, et al. Clinical
               pharmacogenetics implementation consortium guideline for CYP2D6 and CYP2C19 genotypes
               and dosing of tricyclic antidepressants. Clin Pharmacol Ther. 2013.
            </p>
         </li>
         <li id="B14">
            <p><a name="B14"></a> Swen JJ,  Nijenhuis M,  de Boer A,  Grandia L,  der Zee AH M-v,  Mulder H, <em>et al</em>.: <strong> Pharmacogenetics: from bench to byte - an update of guidelines. </strong><p><em>Clin Pharmacol Ther</em> 2011,  <strong>89</strong>(5)<strong>:</strong>662-73.  <a target="_blank" href="/pubmed/21412232">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21412232">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B14" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B14','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B15">
            <p><a name="B15"></a> Swen JJ,  Wilting I,  de Goede AL,  Grandia L,  Mulder H,  Touw DJ, <em>et al</em>.: <strong> Pharmacogenetics: from bench to byte. </strong><p><em>Clin Pharmacol Ther</em> 2008,  <strong>83</strong>(5)<strong>:</strong>781-7.  <a target="_blank" href="/pubmed/18253145">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=18253145">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B15" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B15','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B16">
            <p><a name="B16"></a> Kirchheiner J,  Seeringer A,  Viviani R: <strong> Pharmacogenetics in psychiatry - a useful clinical tool or wishful thinking for the
                  future? </strong><p><em>Curr Pharm Des</em> 2010,  <strong>16</strong>(2)<strong>:</strong>136-44.  <a target="_blank" href="/pubmed/20205659">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=20205659">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B16" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B16','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B17">
            <p><a name="B17"></a> Hodgson K,  Tansey K,  Dernovsek MZ,  Hauser J,  Henigsberg N,  Maier W, <em>et al</em>.: <strong> Genetic differences in cytochrome P450 enzymes and antidepressant treatment response. </strong><p><em>J Psychopharmacol</em> 2014,  <strong>28</strong>(2)<strong>:</strong>133-41.  <a target="_blank" href="/pubmed/24257813">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=24257813">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B17" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B17','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B18">
            <p><a name="B18"></a> Schulz KF,  Altman DG,  Moher D: <strong> CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group
                  randomised trials. </strong><p><em>PLoS Med</em> 2010,  <strong>7</strong>(3)<strong>:</strong>e1000251.  <a target="_blank" href="/pubmed/20352064">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=20352064">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B18" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B18','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B19">
            <p><a name="B19"></a> Dalen P,  Dahl ML,  Bernal Ruiz ML,  Nordin J,  Bertilsson L: <strong> 10-Hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional
                  CYP2D6 genes. </strong><p><em>Clin Pharmacol Ther</em> 1998,  <strong>63</strong>(4)<strong>:</strong>444-52.  <a target="_blank" href="/pubmed/9585799">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=9585799">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B19" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B19','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B20">
            <p><a name="B20"></a>American Psychiatric Association. Diagnostic and statistical manual of mental disorders
               (4th ed., text rev.). Washington, DC: Author; 2000.
            </p>
         </li>
         <li id="B21">
            <p><a name="B21"></a>Flockhart DA. Drug interactions: cytochrome P450 drug interaction table. Indiana University
               School of Medicine (2007). 2013. Available at: http://medicine.iupui.edu/clinpharm/ddis/table.aspx.
               Accessed 8 August 2014
            </p>
         </li>
         <li id="B22">
            <p><a name="B22"></a> de Boer T,  Wieling J,  Meulman E,  Reuvers M,  Renkema G,  den Daas I, <em>et al</em>.: <strong> Application of dried blood spot sampling combined with LC-MS/MS for genotyping and
                  phenotyping of CYP450 enzymes in healthy volunteers. </strong><p><em>Biomed Chromatogr</em> 2011,  <strong>25</strong>(10)<strong>:</strong>1112-23.  <a target="_blank" href="/pubmed/21287583">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21287583">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B22" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B22','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B23">
            <p><a name="B23"></a> Montgomery SA,  Asberg M: <strong> A new depression scale designed to be sensitive to change. </strong><p><em>Br J Psychiatry</em> 1979,  <strong>134</strong><strong>:</strong>382-9.  <a target="_blank" href="/pubmed/444788">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=444788">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B23" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B23','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B24">
            <p><a name="B24"></a> Hakkaart-Van Roijen L,  van Straten A,  Donker M,  Tiemens B: <p><em>Manual Trimbos/iMTA questionnaire for costs asscociated with psychiatric ilness (TiC-P)
                  (in Dutch)</em>. 2002. <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B24" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B24','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B25">
            <p><a name="B25"></a> Berm EJ,  Brummel-Mulder E,  Paardekooper J,  Hak E,  Wilffert B,  Maring JG: <strong> Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM
                  purposes, using LC-MS/MS. </strong><p><em>Anal Bioanal Chem</em> 2014,  <strong>406</strong>(9–10)<strong>:</strong>2349-53.  <a target="_blank" href="/pubmed/24493333">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=24493333">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B25" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B25','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B26">
            <p><a name="B26"></a>Berm EJJ, Paardekooper J, Brummel-Mulder E, Hak E, Wilffert B, Maring JG. A simple
               dried bloodspot method for therapeutic drug monitoring of the tricyclic antidepressants
               amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolites
               using LC-MS/MS. Talanta Advance online publication. doi:10.1016/j.talanta.2014.10.041.
            </p>
         </li>
         <li id="B27">
            <p><a name="B27"></a> Edelbroek PM,  van der Heijden J,  Stolk LM: <strong> Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls. </strong><p><em>Ther Drug Monit</em> 2009,  <strong>31</strong>(3)<strong>:</strong>327-36.  <a target="_blank" href="/pubmed/19349929">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=19349929">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B27" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B27','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B28">
            <p><a name="B28"></a> Uher R,  Farmer A,  Henigsberg N,  Rietschel M,  Mors O,  Maier W, <em>et al</em>.: <strong> Adverse reactions to antidepressants. </strong><p><em>Br J Psychiatry</em> 2009,  <strong>195</strong>(3)<strong>:</strong>202-10.  <a target="_blank" href="/pubmed/19721108">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=19721108">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B28" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B28','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B29">
            <p><a name="B29"></a>EuroQol - a new facility for the measurement of health-related quality of life. The
               EuroQol Group. Health Policy. 1990;16(3):199–8
            </p>
         </li>
         <li id="B30">
            <p><a name="B30"></a> Rush AJ,  Trivedi MH,  Ibrahim HM,  Carmody TJ,  Arnow B,  Klein DN, <em>et al</em>.: <strong> The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating
                  (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic
                  major depression. </strong><p><em>Biol Psychiatry</em> 2003,  <strong>54</strong>(5)<strong>:</strong>573-83.  <a target="_blank" href="/pubmed/12946886">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=12946886">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B30" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B30','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B31">
            <p><a name="B31"></a> Jurgens G,  Jacobsen CB,  Rasmussen HB,  Werge T,  Nordentoft M,  Andersen SE: <strong> Utility and adoption of CYP2D6 and CYP2C19 genotyping and its translation into psychiatric
                  clinical practice. </strong><p><em>Acta Psychiatr Scand</em> 2012,  <strong>125</strong>(3)<strong>:</strong>228-37.  <a target="_blank" href="/pubmed/22128793">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=22128793">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B31" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B31','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B32">
            <p><a name="B32"></a> Skoog I: <strong> Psychiatric disorders in the elderly. </strong><p><em>Can J Psychiatry</em> 2011,  <strong>56</strong>(7)<strong>:</strong>387-97.  <a target="_blank" href="/pubmed/21835102">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21835102">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B32" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B32','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B33">
            <p><a name="B33"></a> March JS,  Silva SG,  Compton S,  Shapiro M,  Califf R,  Krishnan R: <strong> The case for practical clinical trials in psychiatry. </strong><p><em>Am J Psychiatry</em> 2005,  <strong>162</strong>(5)<strong>:</strong>836-46.  <a target="_blank" href="/pubmed/15863782">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=15863782">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B33" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B33','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B34">
            <p><a name="B34"></a> Sangkuhl K,  Stingl JC,  Turpeinen M,  Altman RB,  Klein TE: <strong> PharmGKB summary: venlafaxine pathway. </strong><p><em>Pharmacogenet Genomics</em> 2014,  <strong>24</strong>(1)<strong>:</strong>62-72.  <a target="_blank" href="/pubmed/24128936">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=24128936">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B34" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B34','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B35">
            <p><a name="B35"></a> Wille SM,  Cooreman SG,  Neels HM,  Lambert WE: <strong> Relevant issues in the monitoring and the toxicology of antidepressants. </strong><p><em>Crit Rev Clin Lab Sci</em> 2008,  <strong>45</strong>(1)<strong>:</strong>25-89.  <a target="_blank" href="/pubmed/18293180">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=18293180">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-015-0561-0&amp;bibl=B35" onclick="popup('/sfx_links?ui=s13063-015-0561-0&amp;bibl=B35','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
      </ol>
   </div>
</section>
    <br class="clearall">
<div class="article-alert-signup-div">

<a class="close png_bg" id="closeHelpBox" >close</a>	
<div class="article-alert-signup rounded" > 
<span class="blurb left">Sign up to receive new article alerts from <em>Trials</em></span>

	
				<button name="articleAlertPreference.status" type="button" class="w74 right" onClick="window.location='/my/preferences'">Sign up</button>
	
</div>
</div></div>
    </div></div>
</div>


		</div>
</div>

    <hr class="hide" />
	
    

						
   
  
      
  
                  
  
                  
  
            
  
            
            


<div id="footer">

						
			<span class="views"><a id="mobile-view" href="?fmt_view=mobile">Mobile view</a> | <strong>Desktop view</strong></span>
			
	<div class="content">
    <div class="rounded ">
<div class="wrap-inner ">
        	
    <ul class="desktop">
                                                    
				        <li class="noborder"><a href="http://www.biomedcentral.com/about/tandc">Terms and Conditions</a></li>
<li><a href="http://www.biomedcentral.com/about/privacy">Privacy statement</a></li>
<li><a href="http://www.biomedcentral.com/presscenter">Press</a></li>
	<li><a href="http://www.biomedcentral.com/advertisers">Information for advertisers</a></li>
<li><a href="http://www.biomedcentral.com/about/bmcjobs">Jobs at BMC</a></li>
<li><a href="/support">Support</a></li>
<li><a href="/about/contact">Contact us</a></li>


    
    	    </ul>
    <p id="copyright">&copy; 2015 
	BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business&nbsp;Media.</p>
        </div>
</div>

	</div>

</div>
<div class="springer">
    <a href="http://www.springer.com/" target="blank"><img style="float:right; margin:0;" src="
    //www.biomedcentral.com/images/Springer_Branding_footer_logo.png" /></a>
</div>


<script>window.bmcIsMobile = "classic";</script>					    

<script>
// getElementsByClassName Polyfill
var getElementsByClassName=function(e,t,n){if(document.getElementsByClassName){getElementsByClassName=function(e,t,n){n=n||document;var r=n.getElementsByClassName(e),i=t?new RegExp("\\b"+t+"\\b","i"):null,s=[],o;for(var u=0,a=r.length;u<a;u+=1){o=r[u];if(!i||i.test(o.nodeName)){s.push(o)}}return s}}else if(document.evaluate){getElementsByClassName=function(e,t,n){t=t||"*";n=n||document;var r=e.split(" "),i="",s="http://www.w3.org/1999/xhtml",o=document.documentElement.namespaceURI===s?s:null,u=[],a,f;for(var l=0,c=r.length;l<c;l+=1){i+="[contains(concat(' ', @class, ' '), ' "+r[l]+" ')]"}try{a=document.evaluate(".//"+t+i,n,o,0,null)}catch(h){a=document.evaluate(".//"+t+i,n,null,0,null)}while(f=a.iterateNext()){u.push(f)}return u}}else{getElementsByClassName=function(e,t,n){t=t||"*";n=n||document;var r=e.split(" "),i=[],s=t==="*"&&n.all?n.all:n.getElementsByTagName(t),o,u=[],a;for(var f=0,l=r.length;f<l;f+=1){i.push(new RegExp("(^|\\s)"+r[f]+"(\\s|$)"))}for(var c=0,h=s.length;c<h;c+=1){o=s[c];a=false;for(var p=0,d=i.length;p<d;p+=1){a=i[p].test(o.className);if(!a){break}}if(a){u.push(o)}}return u}}return getElementsByClassName(e,t,n)}
</script>

						



<script type="text/javascript">
if (typeof jQuery == 'undefined') { document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.min.js' type='text/javascript'%3E%3C/script%3E")); }


document.documentElement.id = "js";

var site = {
			abbreviation: "",
	        type: "BMC_NICHE",
        portalId: "9001",
                section: "browse",
                page: "fulltext",
    		
									homePortal: "biomedcentral.com",
		
			siteShowAds: "true",
				showAds: "true",
				url: "trialsjournal.com",
			portal: false,
	        adpage_url: "trialsjournal.com/article/10.1186/s13063/015/0561/0",
        id: "10096",
	name: "Trials",
	plugins: {
		scrollable: (getElementsByClassName("scrollable").length > 0),
				flowplayer: ((document.getElementById("flowplayer") != null) || (getElementsByClassName("myPlayer").length > 0) || (document.getElementById("videoarticle") != null) || (getElementsByClassName("flowplayer").length > 0) || (document.getElementById("audio") != null) || (document.getElementById("elifeplayer") != null)),
		lightbox: ((document.getElementById("image-highlight") != null) || (getElementsByClassName("lightbox").length > 0)),
		thickbox: (getElementsByClassName("thickbox").length > 0),
		altmetric: ((document.getElementById("altmetric") != null) || (getElementsByClassName("altmetric").length > 0))
	}
	
};



if(typeof quoteSearchUri == "undefined") { quoteSearchUri=null; }
</script>



        <script type="text/javascript" src="http://www.bmcimg.com/javascript/journals/behaviours-0.js"></script>






		<script>
	if (site.plugins.scrollable == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.scrollable-1.0.1.min.js' %3E%3C/script%3E")); 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.tools.min.js'%3E%3C/script%3E"));
	}

	if (site.plugins.flowplayer == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/flowplayer-3.2.6.min.js'%3E%3C/script%3E"));
	}

	if (site.plugins.lightbox == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/browse_imagehighlight.js'%3E%3C/script%3E"));
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.colorbox.js' %3E%3C/script%3E"));
	}

	if (site.plugins.thickbox == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/thickbox-compressed.js' %3E%3C/script%3E"));
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/thickbox-flashhidden-patch.js' %3E%3C/script%3E"));
	}
	</script>





            <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery.fancybox-1.3.1.pack-0.js"></script>
            <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery.debug-0.js"></script>
                      <script type="text/javascript" src="http://www.bmcimg.com/javascript/email_preferences/email_preferences-0.js"></script>
                <script type="text/javascript" src="http://www.bmcimg.com/javascript/articles/articles-0.js"></script>
		<div id="fb-root"></div>











        <script type="text/javascript" src="/javascript/plugins/jquery.tagcloud.min-0.js"></script>




<!--[if lte IE 6]>
            <script type="text/javascript" src="/javascript/plugins/DD_belatedPNG_0.0.8a-0.js"></script>
    <script type="text/javascript">
        DD_belatedPNG.fix('.png_bg, ul.primary-nav li a, ul.primary-nav li a span, ul.secondary-nav li a, ul.secondary-nav li a span, ul li i, .plus-button, .facebook, .twitter, .fancy-bg, #fancybox-close');
    </script>
	                <link rel="stylesheet" type="text/css" href="http://www.bmcimg.com/css/hacks/ie6-0.css"/>
    <![endif]-->

<!-- Claudia Whitcombe wanted this comment here -->

       <div class="hide">
      <dl class="google-ad" id="x96banner">
        <dt style="display: block;" class="hide">
          <a class="skyscraper-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</a>
       </dt>
        <dd>
          <!-- OAS AD 'x96' begin -->
          <script type="text/javascript">
            OAS_AD('x96');
          </script>
        </dd>
      </dl>
    </div>  
    
</body>
</html>

